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ABSTRACT
Background: This study examines referrals to a newly established Neuropsychology 
Assessment Service (NAS) within Argyll and Bute. In order for the service to successfully 
develop, it is essential that this provision be monitored to aid future planning.
Methods: Data were gathered from those referrals accepted for assessment by the NAS 
within the first 9 months of the service’s establishment. Information was gathered from the 
clinical psychology department’s database and relevant case-notes.
Results: A total of 15 referrals were analysed in terms of a) the profile of referrals to the 
service b) the nature of the assessment service received c) the outcome of cases. The most 
notable results were the attendance of all 15 referrals for the duration of assessment, 
especially in light of significantly high journey times for many patients to attend their 
appointments.
Conclusions: With initial results being positive, the service will need to plan the next steps 
for developing the NAS, and assess the resource implications for this. Staffing shortages 
and changes in the Health Board’s management and structure may complicate these 
developments.
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INTRODUCTION
Within the Lomond and Argyll Division of NHS Argyll and Clyde, clinical psychology 
services have been historically split between provision to the areas of Lomond, and Argyll 
& Bute. Following a review of ‘Clinical Psychology Services in Lomond and Argyll 
Primary Care Trust’ (Peck. 2001), recommendations were made for a more area-wide 
focus on clinical psychology services within Lomond and Argyll. In response to this report 
plans for a specialist neuropsychology assessment service to the Argyll and Bute 
population were put in motion, as previously only patients within the Lomond catchment 
area had access to this service.
In March 2004 a Neuropsychology Assessment Service (NAS) was established, based at 
the Argyll and Bute Hospital in Lochgilphead, and covering the entire Argyll and Bute 
population. Limited resources mean that the clinic is only held one day a month, allowing 
the Grade B Neuropsychologist to make approximately 3-4 appointments per month. For 
clinical and administrative tasks, the Neuropsychologist’s total allocated input to the 
service is 0.1 w.t.e. A condition of the Neuropsychologist’s sessions in Lochgilphead was 
additional support from the Psychology Assistant based at Argyll and Bute Hospital. The 
number of sessions provided by the Psychology Assistant was not formalized, but it was 
agreed that they would assist in the administering of tests and in follow-up work. The NAS 
also provides the opportunity for Trainee Clinical Psychologists to work within the clinic. 
As a community neuropsychology service, assessment is available to both in- and out­
patients, in a catchment area which covers 26 GP surgeries with an estimated 62, 750 
registered patients (Smith, J. 2003). The geographic area of Argyll and Bute is mainly rural 
and covers approximately 2,600 square miles (NHS A&C Website. 2005). Referrals to the
NAS are made via the Adult Clinical Psychology Service, where the Head of Service
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screens referrals for suitability in discussion with the Neuropsychologist. Once the NAS 
has become more established, consideration may be given as to whether a direct access 
referral system should be adopted.
Within the framework of clinical governance it is hoped that in the future, the NAS may 
progress as part of an integrated care pathway for patients with neuropsychological deficits 
within Argyll and Bute. Whilst no such system exists, it is felt that by first establishing the 
NAS, more formal links to other services may then be established. Ideally the NAS would 
like to feed into a service similar to the Brain Injury Team, which exists within Lomond, 
however as yet Argyll and Bute does not have such a service. The development of links 
with alcohol and dementia services would be a possible progression for the NAS.
To date there has been no evaluation of who is being referred to the clinic, or of the 
assessments that have been required by this population. It is essential for clinical 
psychology to monitor this provision to assist future planning. This project therefore 
proposes an analysis of referrals to the new NAS as a baseline for identifying the current 
provision and as an aid to future service development.
Specific attention must be paid to the rural nature of Argyll and Bute, which includes a 
number of island populations. Transport is a critical issue in rural areas, however it has 
been reported that rural residents are often realistic about the kinds of services they expect 
to be provided locally (Scottish Executive, Rural Affairs Department. 2000). It will be 
important to assess whether patients appear to be willing to make long journeys in order to 
access this specialist service. Similarly it would be important to identify the geographic 
spread of referral origin.
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Guidelines and recommendations exist for specific patient populations, predominantly 
alcohol-related brain damage (Fuller Life. 2004) and dementia (SIGN. 1998). Both 
documents recommend the value of neuropsychological assessment, and given that patients 
can now access this service, such documents may be useful in shaping the future 
development and direction of the NAS.
Aims and Objectives
The aim of this project is to provide an analysis of the referrals to a new neuropsychology 
assessment service provided within Argyll and Bute. This shall be achieved by exploring 
the following:
1. Who used the service and what types of referrals were received?
o To establish which population sub groups are accessing the service, both in 
terms of demographics, geographic location and problem type.
2. What is the nature of the assessment service provided to the referred population?
o It is important to identify whether the current staffing provision is sufficient 
to meet the referral demand, and to establish the assessment needs of this 
population.
3. What were the outcomes of cases seen within the service?
o This has implications for the development of services.
METHOD
A retrospective analysis of referrals to the NAS was carried out, based on data acquired
from their case-notes. Data were collected from all referrals accepted for assessment by the
NAS in the first 9 months of the service. This included referrals accepted from 1st May
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2004 to 31st January 2005. Information was gathered from individual files using a data 
collection form (see Appendix 1:1 for copy of form), the creation of which was guided by 
data collection in previous audits (Townsend & Irvine. 2003, and Smith. 2003). A database 
was established in Access to hold this information, and then the data transferred to Excel 
for subsequent analysis. To protect patient confidentiality, data remained anonymous via a 
randomly allocated identification number, with personal identifiers such as name and date 
of birth excluded from data collection.
RESULTS 
Referral Rates
In total, 15 referrals were accepted for assessment by the NAS between 1st May 2004 and 
31st January 2005. As referrals are accepted by the NAS via the screening of referrals made 
to Adult Clinical Psychology Services, the nature of this system means there are no 
rejected referrals. Figure 1 represents the profile of referrals accepted each month, and 
highlights the 5 referrals which had been waiting for the NAS to begin accepting referrals.
Insert Figure 1 here
Age and gender of referrals
Of the 15 referrals accepted by the NAC for assessment, 9 were male and 6 were female. 
The mean age was 50 (SD = 12) and the median age was 52 (Inter-quartile range = 15).
Referral Source
Figure 2 represents the referral source, highlighting that nearly half of referrals (47%) were 
received from Psychiatry.
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Insert Figure 2 here
Referral Problem
Problem areas requested for assessment by the referral letter can be grouped broadly into 3 
main areas, as highlighted in Figure 3. Assessments for cognitive impairment represent the 
majority of referrals, with approximately one third of these questioning a possible link with 
alcohol/substance abuse. One referral requested the assessment of deficit related to a 
previously diagnosed Axis II Disorder.
Insert Figure 3 here
Geographic Location of Patients
Figure 4 illustrates the catchment areas of those patients accepted for assessment. Within 
the 4 Mid Argyll cases, 3 of them were assessed as inpatients and were therefore based on 
the same site as the NAS. Distance travelled by patients to reach appointments within the 
NAS was calculated from their home postcodes (calculations made by AA Route Planner). 
Due to the rural location of many addresses within the catchment area, particularly those 
located on islands, estimated time-taken to attend appointments were also calculated (AA 
route-planner). The following results represent a one-way journey. The mean distance 
traveled by patients to a single appointment was 33.5 miles (SD = 23) and the median 
distance was 40.7 miles (range = 0 - 69.9 miles). The mean length of time taken to travel to 
a single appointment, as estimated by AA Route Finder, was 87.6 minutes (SD = 64) and
Insert Figure 4 here
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Waiting Time
In those patients who attended the NAS, the mean waiting time between referral and the 
first appointment offered was 30 days (SD = 20) and the median waiting time was 25 days 
(range = 8 - 9 0  days). For these calculations, referrals made before the start of the NAS
thwere recorded as 20 April 2004, which is 2 weeks before the NAS first began seeing 
people, and therefore takes into account when the NAS first began accepting referrals.
Attendance Rate
Figure 5 highlights attendance status to first offered appointments. Despite DNAs and 
cancellations, all 15 patients eventually attended the service for assessment.
Insert Figure 5 here
Formal Neuropsychological Testing
Two of the 15 cases were unsuitable for formal neuropsychological testing. One of the 
patients presented as being under the influence of alcohol and in the other case formal 
testing was not felt to be appropriate. Table 1 shows the variety and frequency of tests used 
within the NAS for the 13 cases administered formal neuropsychological tests. Within the 
13 cases which underwent formal testing, then mean number of tests administered per case 
were 4 (SD = 2) and the median number of tests administered were 4 (range = 1 - 7  tests)
Insert Table 1 here
Appointments
The mean number of appointments attended by patients is 2.8 appointments (SD = 1) and
the median number is 3 (range = 1-5). The Neuropsychologist attended 48% of all
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appointments, and the Trainee Clinical Psychologist and Psychology Assistant each 
attended 26% of all appointments.
Assessment Episode Length
One patient attended his appointment under the influence of alcohol, and therefore could 
not be assessed within the NAS. The remaining 14 patients attended the service for the 
duration of their assessment. The mean length of a completed episode of assessment was 
97 days (SD = 56) and the median length of assessment was 91 days with the range of 0 to 
209 days (0 days refers to assessments which were completed in one day). Length of 
assessment was calculated from 1st appointment attended to the date stated on the patient’s 
assessment report.
Problem Type Following Assessment
Figure 6 shows the basic problem types identified by the Neuropsychologist following 
assessment. It highlights that acquired cognitive deficit was identified in 80% of cases 
assessed.
Insert Figure 6 here
Of the 12 cases with acquired cognitive deficit, Figure 7 highlights the most likely cause of 
the problems as identified by the Neuropsychologist. In some cases there are multiple 
possible causes, e.g. closed head injuries combined with a past history of alcohol abuse. 
For the pie chart below only the most prominent/likely cause has been categorized.
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Insert Figure 7 here
Other service involvement
From the psychology notes it appeared that 53% (n=8) of the cases analysed were only 
currently receiving input from the NAS and the referring service. In the 7 cases with 
additional services involved, these included: Occupational Therapy, Neurology, Psychiatry 
and the Physically Disabled Rehabilitation Unit.
Outcome of cases
Following assessment, 67% (n=10) of the cases were returned to the referrer. At the time 
of writing (July 2005), 33% (n=5) of the cases remain open to the NAS. Two of these cases 
are awaiting re-assessment in order to monitor any change, and 3 cases remain open in 
order to receive follow-up by the Psychology Assistant.
Recommendations Following NAS Assessment
Figure 8 highlights the Neuropsychologist’s recommendations to the referrer following 
assessment, as specified within the assessment report.
Insert Figure 8 here
DISCUSSION
The results of this study provide a description of referrals accepted by the NAS in its first 9 
months.
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Accepted Referrals
A total of 15 referrals were accepted for assessment between 1st May 2004 to 31st January 
2005. Despite a small build-up of referrals before the service began, referrals appear to 
have been infrequent but regular throughout the 9-month period. With an average waiting 
time of 30 days (approximately 1 month) between referral and 1st appointment, initial 
results on wait times appear to be satisfactory. However, these results may be expected in a 
new service, therefore continued monitoring will be required to establish the stability of 
these results.
Demographic Characteristics
The results do not suggest a significant bias towards the assessment of males or females 
within the NAS, with 9 males and 6 females assessed. The majority of patients assessed are 
within the age range between 36 and 70 years old.
Despite appointments with the Neuropsychologist only being available at Lochgilphead, 
the service has been accessed by patients within all 6 catchment areas of Argyll and Bute. 
The average distance travelled one-way from a patient’s home address to the clinic is 33.5 
miles. Estimates suggest that the mean length of time taken to travel by car to a single 
appointment was 87.6 minutes. Taking into account the return journey this is an average 
travelling time of 175.2 minutes per appointment. Such lengthy travelling times are 
inevitable with island populations and poor infrastructure. The attendance of all 15 
referrals for assessment suggests that patients have not been deterred from seeking 
specialist assessment. Whilst such long journey times are undesirable, the current study 
does not demonstrate any negative impact of the Lochgilphead site as the base for this 
service.
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Referral Source and Reason
Five referral sources were identified (Psychiatry, GP, Clinical Psychology, General 
Medicine and Occupational Health), with almost half of accepted referrals received from 
Psychiatry. Fourteen of these referrals required assessment for cognitive impairment, with 
just over a third suggesting a link with alcohol/substance abuse. With referrals being made 
from all 6 catchment areas, there does not appear to be evidence at this stage, that referrers 
from more distant localities are reluctant to refer.
Attendance
In terms of attendance rate, all 15 individuals offered appointments attended the service for 
the duration of their assessment. Whilst cancellations and DNAs did occur, all assessments 
were completed, therefore there were no non-attenders. These are positive results, since 
within the health service, non-attendance rates of between 10 and 50% have been quoted 
within the literature (Henry et al. 1998). It should also be acknowledged that these results 
are in the context of a population who by their very nature are often unreliable, for 
example, due to memory impairments. It is difficult to know why these results are so 
positive, but it would be interesting to see whether this trend continues.
Formal Neuropsychological Testing
The results demonstrate a wide variety of tests used within the NAS, with on average 4 
tests being administered for each patient receiving formal testing.
Appointments
Within the first 9 months of the service almost half of appointments involved the
Neuropsychologist, which reflects the Neuropsychologists attendance at all initial
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assessments. The Trainee Clinical Psychologist and Psychology Assistant were involved in 
approximately a quarter of appointments each. The mean number of appointments attended 
were 2.8 appointments, per assessment episode.
Assessment Episode Length
The mean length of a completed assessment episodes were 97 days (approximately 3 
months). Through further analysis of those cases with a larger episode length, this 
appeared to be due to a delay in the writing of assessment reports. In some cases this was 
due to waiting for information from other services. However, in the majority of cases it is 
not clear why such long gaps exist between the patient’s last appointment and the 
completion of their assessment report. All assessment reports are completed by the 
Neuropsychologist, and by nature are lengthy and detailed. There may therefore be an 
issue regarding whether the balance of time between clinical work and administrative work 
is currently functioning at the correct level. This is something the service will need to 
consider.
Problem Type Following Assessment
Following assessment, 80% of cases were identified as having acquired cognitive deficits.
Whilst multiple possible causes may exist, closed head injuries and alcohol related brain
damage have been the most prominent causes. Of the patients with closed head injuries,
some included the victims of road traffic accidents. It may be predicted that the NAS will
continue to regularly assess the victims of such accidents, since the incidence of serious
road traffic accidents within Argyll and Bute has been reported as being significantly
higher than the Scottish average (Argyll and Bute Council. 2004). Patients with dementia
have been seen less frequently within this referral population. These results may be a
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reflection o f ‘suspect’ dementia referrals going to another service; especially since a rural 
dementia service exists within the area. If this is the case, it is positive that such patients 
are accessing a service, but also of some concern that mis-diagnosis may result from a lack 
of specialist neuropsychological assessment. It is recommended by SIGN (1998) and NICE 
(2001), that all patients with dementia receive neuropsychological assessment.
Other Services Involved
53% of the cases did not appear to have other services simultaneously involved in the 
assessment/care of the case, other than the NAS and the referring service. As this data were 
gathered only from clinical psychology case-notes, a clear picture of other service 
involvement may not have been provided by the referrer or patient, therefore these results 
may be inaccurate.
Outcome of cases
Following assessment the majority of cases (67%) were returned to the referrer, with 
recommendations for further referrals or future management. Recommendations from the 
neuropsychology assessment reports vary greatly, and with only the analysis of 15 cases no 
patterns have currently been identified. One possible implication of the new NAS may be 
an increase in referrals for neuro-imaging, which may therefore begin to affect their 
service. This would be an area in which future links with the NAS may be established 
more formally.
At the time of writing (July, 2005) 33% (n=5) of cases remain open to the NAS. The 
Neuropsychologist has been providing supervision to the Psychology Assistant in the
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follow-up of 3 of the cases. This is mainly in the form of advice and support for patients in 
the management of their specific cognitive impairments.
SUMMARY AND CONCLUSIONS
This study was only able to look at 15 referrals, and it is usually considered preferable to 
have a larger number of referrals to analyse when making inferences. Due to a low referral 
rate, this small data set is unavoidable, but may be viewed as a valuable baseline for future 
audit, and as providing useful information regarding a newly established service.
Future Implications
Following the departure, approximately 5 years ago, of the Neuropsychologist based 
within Argyll and Bute, clinical psychology services were unable to offer a specialist 
neuropsychology service. Referrals for neuropsychological assessment were therefore 
unable to be accepted, with referrers having to find alternative services, which were 
possibly less appropriate or outwith Argyll and Bute. The presence of the current specialist 
service may therefore now reduce the incidence of inappropriate referrals and increase the 
incidence of appropriate referrals to other services within Argyll and Bute. Ultimately the 
NAS allows for more accurate assessment and diagnosis, which can only enhance the 
effectiveness of other service’s for the benefit of the patient.
The most positive results from this study were the 0% rate in non-attenders to the service,
especially in the context of long traveling times by many patients to reach their service.
Whilst results to date are encouraging, the NAS may wish to consider the future planning
of appointment times to suit patient’s individual journeys.
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With the results of this study being generally positive, the NAS will now need to consider 
the future development and marketing of the service. This may involve the promotion of 
the NAS to GPs, psychiatry, the rural dementia team, neurology, alcohol services etc., to 
allow for the development of more formal links between services for adults with 
neuropsychological deficits within Argyll and Bute. The service may also begin to 
consider whether a direct access referral system should now be adopted. Whatever plans 
are made to take the NAS forward, the resource implications will have to be carefully 
considered, which may need to be facilitated within another study.
Possible Complications
A condition of the Neuropsychology provision was input from the Psychology Assistant 
based at Lochgilphead. In April 2005 the Psychology Assistant left the service which 
resulted in the clinic temporarily ceasing to function. The service will have a Psychology 
Assistant in post by July 2005, when the service will resume. This has implications for 
those cases which remain open to the NAS, and is likely to result in a backlog of referrals. 
Such a backlog may result in longer assessment episodes, and whilst this may not be as 
devastating for a service with such a low referral rate, it may be important for this to be 
monitored.
In May 2005, during the completion of this project, the future dissolution of NHS Argyll
and Clyde was confirmed (NHS A&C News Release. May 2005). At the time of writing, a
consultation process is currently underway, which proposes that the responsibility for the
services provided for the people of Argyll and Clyde could be shared between NHS
Greater Glasgow and NHS Highland. It is not clear how long this consultation process will
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take, and therefore the development of the NAS may be affected due to uncertainties 
regarding structure and management.
Conclusion
Whatever the future outcome of Argyll and Clyde it is important that services continue to 
monitor and evaluate their provision. The results of this study shall be presented to 
members of the service in August 2005 for discussion (Appendix 1:2 contains the 
PowerPoint slides to this presentation). Hopefully this study will provide a valuable 
baseline for future audit and service development, despite the uncertain climate.
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FIGURE 1: Number of Accepted Referrals to NAS each Month
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FIGURE 2: Referral Source of Accepted Referrals
Referral Source of Accepted Referrals
7%7m
13% I
47%
20%
■  Psychiatry  
(n=7)
®GP
(n=3)
□  G eneral 
M edicine 
(n=2)
□  Clinical 
Psychology 
(n=2)
□  O cupational 
Health 
(n=1)
FIGURE 3: Problem Type as Stated by Referral
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FIGURE 4: Number of Cases Referred from Each Catchment Area
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FIGURE 5: 1st Offered Appointment Status
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FIGURE 6: Problem Type Following Assessment
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FIGURE 7: Most Prominent/Likely Cause of Acquired Cognitive Deficit
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FIGURE 8: Neuropsvchologist Recommendations
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Table 1: Table to Show the Frequency of Tests Used
Test Name No. of Times 
Administered
% of Total 
Frequency of 
Tests 
Administered
Repeatable Battery for the Assessment of 
Neuropsychological Status
9 16.7%
Wechsler Test of Adult Reading 8 14.8%
Wechsler Adult Intelligence Scale 6 11.1%
Hayling and Brixton Tests 4 7.4%
Rivermead Behavioural Memory Test 4 7.4%
Wechsler Memory Scale 4 7.4%
Controlled Word Association Test 3 5.6%
Addenbrook’s Cognitive Examination 2 3.7%
Behavioural Assessment of Dysexecutive Syndrome 2 3.7%
Behavioural Inattention Test 2 3.7%
Cardiovascular Risk Analysis Questionnaire 2 3.7%
Letter Verbal Fluency Task 2 3.7%
Category Verbal Fluency Test 1 1.9%
Controlled Oral Word Association Test 1 1.9%
Raven Standard Progressive Matrices 1 1.9%
Revised Token Test 1 1.9%
Rohmberg Test 1 1.9%
Visual Retention Test 1 1.9%
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Chapter 2: Systematic Review
Systematic review submitted in partial fulfilment of the requirements for the degree of
Doctorate in Clinical Psychology
The impact of perceived stigma on psychopathology in people with
epilepsy:
A systematic review of the literature.
Prepared in accordance with the requirements for submission to Seizure
(See Appendix 2.1)
Katherine Bruce
Section of Psychological Medicine,
Division of Community Based Sciences, 
Academic Centre,
University of Glasgow, Gartnaval Royal Hospital, 
1055 Great Western Road,
Glasgow G1 OXH 
Tel: 0141 211 3927 
Fax: 014 357 4899
ABSTRACT
Background: Hermann and Whitman (1986) proposed a Multietiologic Model regarding 
the aetiology of psychopathology in people with epilepsy. Within this model they 
hypothesised a range of psychosocial variables that may contribute towards the 
development of psychopathology. One of the proposed variables was perceived stigma, 
however there was limited evidence to support this hypothesis when the model was 
initially proposed. The current paper therefore presents a systematic review of the literature 
in order to evaluate the impact of perceived stigma on psychopathology in people with 
epilepsy.
Method: An electronic search of databases and a manual search of relevant journals 
identified 327 articles. Studies which were repeated or irrelevant were excluded, leaving 51 
papers that were subjected to the inclusion/exclusion criteria.
Results: Thirteen studies met the inclusion criteria. They were assessed on their 
methodological quality and assigned a quality rating. Study characteristics were described, 
methodological strengths and weaknesses discussed, and results evaluated.
Conclusions: This review suggests that there is evidence of an association between 
perceived stigma and psychopathology in people with epilepsy. However our 
understanding of the nature of this association is limited. There is a need for representative, 
longitudinal studies to further investigate the relationship and attribute causality.
Kepvords: epilepsy, stigma, psychopathology
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INTRODUCTION
Research has identified that people with epilepsy have increased psychiatric morbidity 
compared with normal controls [1] [2] [3]. There has therefore been interest by researchers 
into the causes of these elevated levels of psychopathology. Hermann and Whitman (1986)
[4] proposed a Multietiologic Model regarding the aetiology of psychopathology in 
epilepsy. In conceptualising the relationship between epilepsy and psychopathology, their 
model refers to three categories of etiologic factors; 1) neuroepilepsy factors 2) medication 
factors and 3) psychosocial factors. Neuro-epilepsy factors refer to a range of biological 
and seizure-related variables; for example seizure frequency, seizure type and duration of 
disorder. Medication factors are also considered; including the number, type and dosage of 
medication. Hermann and Whitman developed their model in response to a historical focus 
on the biological causes of psychopathology in people with epilepsy; which generally 
neglected the impact of psychosocial factors. Their psychosocial hypothesis acknowledges 
the ‘unique social and interpersonal stresses’ that people with epilepsy may be exposed to, 
and the effect these stresses can potentially have on psychopathology [4]. Additional 
stresses associated with epilepsy include embarrassment and loss of personal dignity which 
may be associated with seizures; and the uncertainty around when or where seizures will 
occur. Hermann and Whitman’s model proposes a range of psychosocial factors which 
may predispose the individual to various forms of psychopathology, including perceived 
stigma, discrimination, social exclusion, sense of alienation, lack of social support, fear of 
seizures, feelings of helplessness, hopelessness and loss of control. It is proposed that these 
psychosocial variables may interact with neurological factors in complex ways towards the 
development of psychopathology, but hypotheses regarding the nature of these interactions 
were not made explicit.
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In theorizing about the development of depression in epilepsy, Hermann [5] has referred to 
the learned helplessness model, which suggests that depression is a consequence of a 
person’s belief in their ability to control the outcome of events. Hermann proposes that 
people with epilepsy are regularly exposed to uncontrollable aversive events, which can 
produce a pattern of emotional, motivational and cognitive disorders that present as 
anxiety. If these events are prolonged or perpetuated they may result in depression. 
Hermann suggests that learned helplessness may be associated to seizure-related factors, 
given the unpredictable, uncontrollable and potentially dangerous nature of seizure events. 
In addition, psychosocial factors associated with epilepsy may also be considered 
unpredictable and outwith the control of the person with epilepsy e.g. discrimination, 
employment difficulties, and social exclusion.
The current review is concerned with perceived stigma, which is a particular psychosocial 
factor highlighted in Hermann and Whitman’s Multietiologic Model. In defining the social 
phenomena of stigma, Goffman [6] describes it as an attribute that is discreditable to one’s 
personal identity. He observes stigma as the relationship between an attribute and a 
stereotype, therefore highlighting how people can be linked with socially undesirable 
characteristics when they are seen to have a discrediting attribute such as epilepsy. 
Quantitative measures of perceived stigma have been adapted and developed for people 
with epilepsy [7] [8], allowing researchers to measure levels of perceived stigma alongside 
other psychosocial variables within epilepsy research. For example, Jacoby [7], developed 
a scale in which subjects are asked whether, because of their epilepsy, they felt that other 
people (1) were uncomfortable with them (2) treated them as inferior and (3) preferred to 
avoid them. The Multietiologic Model therefore hypothesised that a person’s perception of
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being negatively defined by their epilepsy may contribute towards the development of 
psychopathology.
In 1986 when Hermann and Whitman [4] included perceived stigma in their model, they 
were unaware of any published empirical evaluations regarding the relationship between 
measures of perceived stigma and psychopathology. The proposed review therefore 
attempts to identify whether the research over the past 20 years has attempted to evaluate 
this relationship, and investigate the extent to which perceived stigma impacts on 
psychopathology. A number of reviews have made reference to the research on the stigma 
of epilepsy and its relationship with psychopathology and quality of life [9] [10]. However, 
these studies did not include a thorough analysis of methodology, and did not focus 
specifically on the relationship between perceived stigma and psychopathology.
Psychopathology has been defined as ‘the systematic study of abnormal experiences, 
cognition and behaviour; the study of the products of a disordered mind’ [11]. However, a 
recent review paper on psychiatric co-morbidity in epilepsy acknowledges the ‘diverse and 
confusing ways’ in which the term psychopathology has been used within epilepsy 
research [12]. Hermann and Whitman [4] also acknowledge ‘psychopathology’ as a non­
specific term. They describe the epilepsy literature as having 6 major areas of 
investigation: psychosis, aggression, sexual dysfunction, affective disorder, personality and 
behavioural change. In addition they refer to ‘a large and heterogeneous category -  general 
psychopathology -  characterised by the use of standardised measures of personality and 
other indications of psychopathology (e.g. rated as psychiatric hospitalisations)’. Thus, 
whilst investigators speak of “psychopathology in epilepsy” there are at least six distinct 
areas that are the focus of investigations. For the purpose of this review, the term
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psychopathology shall remain wide; including the areas outlined by Hermann and 
Whitman [4], and any other measures of general emotional well-being. In addition, this 
review shall also reflect upon studies which include variables viewed as indicators or 
symptoms of psychopathology, for example low self-esteem. This will allow for a more 
comprehensive discussion of the literature.
The objective of this paper is to investigate the impact of perceived stigma on 
psychopathology in people with epilepsy. This shall be achieved through a systematic 
review of the available research and an evaluation of the methodological quality of these 
studies. Whilst the current review is concerned with the impact of a single psychosocial 
variable on psychopathology, it will also be important to identify any factors which may 
influence this relationship. In consideration of the learned helplessness model, the 
significance of factors such as seizure frequency, perceived seizure severity, adjustment to 
epilepsy, employment difficulties and social isolation, will be important when considering 
the results of this review.
METHODS 
Search Strategy 
Computerised Database Search
The following electronic databases were searched:
• PsychlNFO (1967-2006)
• Medline (1966-2006)
• CINAHL (1982-2006)
• EMBASE (1980-2006)
• British Nursing Index (1985-2006)
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• EBM Reviews -  Cochrane Database of Systematic Reviews
• EBM Reviews -  Database of Abstracts of Reviews of Effects
• EBM Reviews -  Cochrane Central Register of Controlled Trials
The following key words were used as search terms: [epilepsy] combined with [stigma] or
[discrimination] and the results from this combined with the results gained from searching 
[psychosis] or [aggression] or [sexual dysfunction] or [affective disorder] or [personality 
change] of [behaviour change] or [psychopathology] or [psychosocial functioning] or 
[psychological outcome] or [mental health] or [psychological wellbeing] or [quality of life] 
or [anxiety] or [depression] or [self-esteem] or [hopelessness].
Reference Searching
The references of all papers considered for inclusion were also searched, in order to 
identify further relevant papers.
Hand Search of Related Journals
Any journals that had published three or more of the papers considered for inclusion were 
also searched for any further relevant studies. Journals included in the manual search were: 
Seizure, Epilepsia, Epilepsy and Behaviour, Social Science and Medicine.
Article Inclusion and Exclusion Criteria
Studies were included if they met the following criteria:
• Include a measure of participant’s perceived stigma in relation to their epilepsy.
• Consider the relationship between levels of perceived stigma and psychopathology 
in adults with epilepsy. Including:
35
o Studies measuring ‘psychopathology’, ‘mental illness’ or 
‘psychological/emotional well-being’ 
o Studies measuring a specific type of mental illness e.g. depression, anxiety, 
o Studies measuring variables which may be indicative of impaired 
psychological functioning e.g. symptoms of depression and anxiety or low- 
self-esteem.
The following exclusion criteria were applied:
• Case studies.
• Selective reviews, expert opinions or editorials.
• A qualitative methodological approach.
• Unpublished dissertations.
• Studies not reported in English.
• Non-clinical studies (statistics papers, discussion papers, commentaries).
• Studies reporting the development/validation of a clinical measurement tool.
• Studies on children and/or adolescent populations.
RESULTS
Outcome of Search Process 
Electronic Search
The electronic search initially generated 217 papers. Repeated titles were excluded leaving 
143 papers. Sixty-two papers were excluded on the basis of their titles, and 52 further 
papers were excluded after scrutinising their abstracts. This left 29 papers that were read 
and the contents checked against the inclusion and exclusion criteria. Eight papers from 
this search were identified as meeting the inclusion criteria.
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Reference Search
A further 63 titles were identified by a hand search of the eight identified paper’s reference 
sections. Of these, 46 were excluded once the abstracts were checked and 12 were 
excluded after reading the papers, leaving the remaining 5 to be added to the review.
Hand search of Relevant Journals
Six journals were identified as having published at least 3 of the studies considered for 
inclusion. The contents of these six journals were searched from 1986 and from this 47 
titles were considered for inclusion. Of these, 42 abstracts were checked and 5 original 
papers were checked. None of them were included in the review.
The outcome of the search process is shown schematically in Figure 1.
Insert Figure 1 here
Study Quality and Rating Criteria
The studies being reviewed all used observational methods. Criteria were therefore devised 
to assess the quality of studies specific to this review. These were guided by expert opinion 
(Greenhalgh. 1997) [13] and formal guidelines produced by the Scottish Intercollegiate 
Guideline Network [14] and the Cochrane Collaboration [15].
The first stage of quality assessment referred to the design of the studies, as this is a key 
consideration in assessing the extent to which the studies are able to evaluate the impact of 
perceived stigma and psychopathology in people with epilepsy. Longitudinal designs are
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the most appropriate design for answering this question as they are able to ‘establish the 
direction and magnitude of causal relationships’ [16], unlike cross-sectional designs. 
Within the first stage of quality assessment studies were therefore assigned according one 
of the following ratings:
1: Longitudinal design
2: Cross-sectional design 
Within these principle ratings, the studies were further assessed according to three further 
quality areas:
a) Generalizability of the findings:
Whether the sample is representative is an important quality criterion, as it reflects the 
extent to which the results can be generalised to the target population. To account for 
selection bias, the quality criterion therefore considers whether studies utilised an 
appropriate sampling strategy to select their participants.
b) Confounding variables:
The Cochrane Collaboration highlight that in observational studies it is important to 
identify and account for potential confounds, by making judgements about what confounds 
are important and the extent to which these were appropriately measured and controlled for 
[15]. As highlighted within Hermann and Whitman’s Multietiologic Model [4] a variety of 
variables have been proposed to influence psychopathology in people with epilepsy; 
including demographic, neuro-epilepsy, psychosocial and medication variables. Swinkels 
et al. [17] recommend that all these factors should be considered when investigating 
psychopathology in epilepsy. It is therefore an important quality criterion to establish 
whether the papers reported variables within each of these four categories and considered 
them in the analysis. The quality criteria takes into account the extent to which studies 
have considered possible confounding factors, such as those highlighted in Table 1.
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Insert Table 1 here
c) Reliability/validity of assessment measures:
In order to establish whether perceived stigma and psychopathology are being measured in 
a reliable and valid way, the quality criteria assesses the reliability and validity of the 
measures used.
Each study was assessed on how well they met these three quality areas and assigned a 
rating of either ‘Good’, ‘Adequate’ or ‘Poor’ within each area. An overall quality rating of 
i) ii) or iii) were subsequently allocated according to the following criteria:
i) = Two or more ratings of ‘Good’
ii) = Two or more ratings of ‘Adequate’ or one of each (‘Poor’, ‘Adequate’, ‘Good’)
iii) = Two or more ratings of ‘Poor’
This was combined with the initial quality rating assigned according to the design of the
study i.e.) 1 = longitudinal, 2 = cross-sectional. Appendix 2.2 contains the rating system 
for these quality criteria, in which l(i) represents the highest quality rating and 2(iii) 
represents the lowest. Whilst the overall quality ratings were dependent upon key areas of 
quality, the results section also gives more detailed consideration to the strengths and 
weaknesses of each of the reviewed studies.
Data Extraction
Thirteen papers were identified as meeting criteria for this review. To increase reliability 
each study was evaluated by the author and an independent rater, using the quality criteria 
outlined in Appendix 2:2. The raters assigned the same overall quality rating to nine of the
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papers. The other four papers were discussed between the two raters in order to establish 
an agreed rating for all of the studies.
RESULTS
Of the 13 studies reviewed, four papers were rated 2(i), three papers were rated 2(ii) and 
six papers were rated 2(iii).The summarised characteristics and quality ratings of each 
study are provided in Table 2.
Insert Table 2 here
The key question in this review concerns the possible relationship between stigma and 
psychopathology, and as discussed in the introduction, one of the problems has been a 
clear definition of the term psychopathology. For this reason, the results are presented in 
three sections, with each concerning a distinct way in which psychopathology has been 
measured. As some studies adopted a wide range of measures, this means they may be 
referred to in more than one section of the results. For ease of reference, Table 3 presents 
the studies corresponding to each section of results, alongside their assigned quality 
ratings.
1) Perceived Stigma and General Psychopathology
General psychopathology was seen to be measured by the assessment of overall emotional 
well-being, regardless of specific types of disorders. Four of the reviewed studies were 
found to have considered the association between perceived stigma and overall emotional 
well-being (Hermann et al. [18], Herodes et al. [19], Lee et al. [20] and Jacoby [21]). 
Details of these studies are outlined in Table 2.
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i) Findings
Each of the studies used samples of participants from a different country. Nevertheless, 
they all found a significant association between their measures of emotional well-being and 
perceived stigma. Perceptions of stigma were associated to lower emotional well-being; 
however the nature of this relationship varied amongst the studies. Lee et al. [20] aimed to 
identify factors which contributed to feelings of stigma, and found that emotional well­
being was independently and significantly associated with perceived stigma. Similarly, 
Herodes et al. [19] found that perceived stigma independently and significantly contributed 
to scores of emotional well-being, alongside ‘seizure frequency’ and ‘duration of disease’. 
Unlike other papers, Jacoby [21] did not account for confounding variables within their 
analysis, however they found higher scores on the stigma scale were associated to lower 
emotional well-being. The paper by Hermann et al [18] is a significant study within this 
review, because it was completed by the authors who originally proposed the 
Multietiologic Model of psychopathology in epilepsy. In order to contribute evidence for 
this model, neurological, psychosocial, demographic and medication variables were 
investigated. Whilst perceived stigma was found to be significantly associated with 
psychopathology, it was not identified as an independent predictor of psychopathology. 
The most powerful predictors of psychopathology were ‘increased number of stressful 
events in the past year’, ‘poor adjustment to epilepsy’ and ‘financial stress’. Psychosocial 
factors were generally identified as having the strongest relationship with overall 
psychiatric distress.
ii) Methodological issues
As highlighted in Table 3, the quality of the studies outlined were varied; two received a 
quality rating of 2(i) and two received a quality rating of 2(iii).The studies were all cross-
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sectional in design, which means causality cannot be inferred between the relationship of 
perceived stigma and overall emotional well-being. There was variability in the extent to 
which confounding variables were considered in the analysis. Table 2 shows that one study 
did not take into account any confounding variables, while the other three considered a 
wide range of neuro-epilepsy psychosocial and demographic factors. Despite this, only two 
studies accounted medication variables.
The generalizability of the results are limited due to sampling biases, as highlighted in 
Table 2. Three studies recruited participants from specialist inpatient units, whilst the other 
focused on a sample of participants with well-controlled epilepsy. In addition, due the 
exclusion criteria, the results are not generalisable to people with a learning disability. In 
measuring psychopathology, none of the studies utilised standardized clinical diagnostic 
systems. They each used self-report questionnaires, only one of which was specifically 
designed to assess overall psychiatric status (General Health Questionnaire [22]). The other 
three studies used questionnaires of quality of life or health status, which included domains 
that assessed overall emotional functioning (RAND 36-Item Health Survey (RAND-36) 
[23], Nottingham Health Profile [24] and Quality of Life in Epilepsy Scale [25]).
iii) Conclusions
The results provide strong support for an association between perceived stigma and overall 
emotional well-being. Each study measured a different range of variables; therefore it is 
difficult to draw conclusions about which variables are most significant to how stigma 
relates to psychopathology. Within the four main categories of variables, psychosocial 
factors appeared to be most strongly associated with psychopathology.
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2) Perceived Stigma and Specific Forms of Psychopathology
Seven studies considered the association between perceived stigma and specific types of 
psychopathology. Three studies investigated the association of stigma with depression and 
anxiety (Baker et al. [26], Amtson et al. [27] and Lee et al [20]), two studies investigated 
only depression (Hermann and Whitman (1989) [28] and Dilorio et al. (2004) [29]) and 
two studies investigated depression and neuroticism (Olley [30] [31]). The measure of 
neuroticism may be regarded as an assessment of anxiety, as it was an instrument used to 
screen for generalised anxiety disorder (The Crown Crisp Experiential Index [32]). It 
should also be noted that the studies by Olley [30][31], presented different analyses of the 
same set of data.
i) Findings
Six studies found that higher scores of depression were significantly associated to 
perceived stigma [20][27][28][29][30][31], Some studies provided analysis of factors 
predicting perceived stigma, whilst others reported analysis of factors predicting 
depression. In addition, the study by Dilorio et al. [29] investigated a psychosocial model 
of medication self-management among people with epilepsy. The results supported the 
model’s prediction that perceived stigma was directly related to self-efficacy and 
depressive symptoms. The studies by Olley et al [30][31] found that depression and stigma 
were both independently related to each other; when other clinical and demographic 
variables were accounted for. Depression and social support were the only variables 
identified as being independently and significantly associated with perceived stigma. In 
addition, perceived stigma, emotion adjustment and adjustment to seizure were the only 
variables identified as being independently and significantly associated with depression. 
These results were in contrast to the findings of Lee et al [20], who did not identify
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depression as being an independent predictor of stigma; suggesting the relationship was 
influenced by other significant variables. This relationship may have been influenced by a 
variety of other factors found to be significantly related to stigma; including reduced 
quality of life, introverted or neurotic personality, helplessness, low problem solving 
control and problem solving confidence, anxiety, and low self-esteem. Similarly, Hermann 
and Whitman [28] found that stigma was not an independent predictor of depression. 
Whilst eight variables were found to have a significant association with depression, only 
four were found to be independent predictors of depression; an increased number of 
stressful life events during the past year, poor adjustment to epilepsy, financial stress and 
female gender. However, Hermann and Whitman’s analysis does not allow us to make 
inferences about the relationship between perceived stigma and these variables. This is an 
important paper, as it aimed to determine the relationship between psychosocial variables 
and depression, in the context of the multietiological model they originally proposed. It is 
interesting that they did not identify any significant correlations between their measure of 
depression and potential neuro-epilepsy or medication risk factors. It is unclear whether the 
study by Baker et al [26] found a significant association between perceived stigma and 
depression; however their stepwise multiple regression analysis did not identify stigma as a 
predictor of depression, or depression as a predictor of stigma.
Within the studies which measured anxiety, they all identified a significant association 
between perceived stigma and anxiety. Baker et al. [26] examined the relationship between 
clinical, demographic and psychosocial variables and found perceived stigma was one of 
eight significant predictor variables for anxiety. When perceived stigma was the dependent 
variable there were four significant predictor variables; perceived impact of epilepsy, age, 
anxiety and seizure frequency. However, Lee et al. [20] found that anxiety was not
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independently associated with feelings of stigma, suggesting the association with stigma 
was influenced by other variables. These variables may have included quality of life, 
introverted or neurotic personality, helplessness, low problem solving control and problem 
solving confidence, depression, and a low self-esteem; which were also found to have a 
significant relationship with stigma. Similar results were found by Olley [28][29], who did 
not identify neuroticism as being independently associated to stigma following a multiple 
regression analysis. In additional analysis, stigma was also found not to be an independent 
predictor of neuroticism.
ii) Methodological issues
The seven studies varied in quality; one was rated 2(i), three were rated 2(ii) and three 
received ratings of 2(iii). As shown in table 2, all of these studies were cross-sectional; 
therefore causality could not be established between perceived stigma’s association with 
anxiety and depression. In addition, the generalizability of the results is limited, as most of 
the studies reported sampling biases. For example, samples were recruited from specialist 
epilepsy centres, inpatient units and self-help groups. One study used a geographical 
cohort, however it also had methodological limitations. A third of the sample were 
diagnosed by their GP and not an epilepsy specialist, therefore increasing the possibility of 
mis-diagnosis. Due to exclusion criterion, the results are not generalisable to people with a 
learning disability. In addition, participants within these studies were recruited from Korea, 
America and Nigeria; therefore the relationships between perceived stigma and 
anxiety/depression have not been investigated within a European sample of participants. 
Studies varied according to the extent to which they considered confounding variables in 
the relationship between perceived stigma and specific forms of psychopathology. As 
highlighted in Table 3, some papers did not account for any variables within the analysis
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[29][27] whilst others considered a wide range of neuro-epilepsy, medication and 
demographic variables [26] [20], In the measurement of anxiety and depression, all of the 
studies utilised previously published self-report questionnaires. The results of these studies 
do not therefore evaluate the relationship between perceived stigma and clinically 
diagnosed levels of anxiety and depression. Olley [28][29] took care to establish the 
validity of the measures for use with a Nigerian sample; however it was not clear whether 
this had been considered within the Korean study by Lee et al. [20],
iii) Conclusions
The reviewed studies provide evidence to support an association between perceived stigma 
and symptoms of anxiety and depression. However, variability in the design of these 
studies makes it difficult to draw further conclusions regarding the strength and nature of 
these associations. In the investigation of specific forms of psychopathology, the research 
is limited to anxiety and depression.
3) Perceived Stigma and Factors Related to Psychopathology
Six studies considered the association between perceived stigma and measures which were 
considered relevant to psychological well-being [20][21][27][32][33][34].These include 
factors which were viewed as being significantly related to psychopathology, or had 
implications for participants’ level of psychological well-being. Amongst the studies, data 
were collected from participants living within the USA, Korea and a wide range of 
European countries. It should be noted that the studies by Jacoby [21] [31] present different 
results on the same the same sample of participants.
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i) Findings
Whilst not being diagnostic, epilepsy related worries refer to specific anxieties and may 
therefore be considered relevant to psychopathology. Five studies referred to levels of 
epilepsy related worries and perceived stigma (Lee et al [20], Jacoby [21][33], Baker et al. 
[32], Ratsepp et al. [35]). They demonstrated similar results, finding that greater levels of 
perceived stigma were related to higher levels of anxiety about epilepsy. The types of 
worry which were measured included fear of having a seizure during the next month, 
worry about embarrassment resulting from having a seizure, and worry about the adverse 
effects of medication if taken for a long time. Only Lee et al. [20] performed regression 
analysis on their data; and whilst epilepsy-related worries were significantly correlated to 
feelings of stigma, they were not independently associated with stigma [20], This 
suggested that the impact of epilepsy-related worries on stigma related to other significant 
variables; which may include quality of life, introverted or neurotic personality, 
helplessness, actual discrimination, problem-solving control, problem solving confidence, 
anxiety and depression. Of significant note, were the results of Baker et al [32] which 
recruited participants from a range of European countries. Following the analysis of data 
from eight European countries, worry about epilepsy was only significantly associated with 
stigma within four of the countries; France, Germany, Netherlands and UK. These results 
therefore suggest important cross-cultural variations in the way perceived stigma relates to 
other clinical and demographic variables.
Three studies measured self-esteem, which is a significant symptom of depression and 
reflects an area of psychological well-being (Jacoby [21] Amston et al. [27] and Lee et al.
[20]). The studies all showed support for a relationship between perceived stigma and low 
self-esteem. Only one study performed regression analysis on their data; and whilst low
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self-esteem was found to be significantly correlated with feelings of stigma, it was not 
independently associated to stigma [20], This suggests that the impact of self-esteem on 
stigma was related to other significant variables; although it cannot be inferred which 
variables or in what way.
Two studies provided measures related to life satisfaction (Amston et al. [27] and Baker et 
al. [32]). Both studies reported results which identified that perceived stigma was 
negatively and significantly associated to life satisfaction. However, within the study by 
Baker et al [32] these results were not replicated across all cultures. Analysis within eight 
European countries found that negative feelings about life as a whole were only 
significantly associated to stigma within the samples from Italy, Germany, Spain and UK.
ii) Methodological issues
As highlighted in Table 3, the quality of studies investigating this area of psychopathology 
were generally quite poor; only one study received a quality rating of 2(ii) whilst the other 
five received quality ratings of 2(iii). All of the studies were cross-sectional and therefore 
limited by their design, as causality cannot be inferred in the relationships between 
perceived stigma and the variables measured within these studies. The majority of studies 
demonstrated sampling bias; recruiting from support groups, specialist epilepsy centres and 
populations with well-controlled epilepsy. Exclusion criteria also mean that the majority of 
results are not generalisable to people with a learning disability. There was significant 
variability in the extent to which studies accounted for confounding variables in their 
analysis. Two studies accounted for a wide range of neuro-epilepsy, psychosocial and 
demographic factors. However, four of the studies only conducted simple analysis between 
the relationships of variables and therefore did not account for other significant factors. In
48
addition, there may some criticism of the measures used to assess the psychological 
variables within these studies. The reliability and validity of some of the assessment 
measures used was unclear; particularly with regards to the cultural validity of measures 
used within the Korean sample of participants.
Hi) Conclusions
The reviewed studies support an association between perceived stigma and epilepsy 
related-worries, low self-esteem and reduced life satisfaction. These are therefore 
identified as possible mechanisms by which perceived stigma and psychopathology may be 
associated. Unfortunately, it is not possible to infer causality, therefore it remains unclear 
how these variables are related to the association of stigma and psychopathology.
DISCUSSION
Overview
The objective of this review was to investigate the impact of perceived stigma on 
psychopathology in people with epilepsy. Through a systematic search of the literature 13 
studies were reviewed in order to explore this relationship. Overall, the results of these 
studies provide evidence to support a significant association between perceived stigma and 
psychopathology across a wide range of cultures. Symptoms of anxiety, depression and 
overall emotional well-being were all found to be associated with perceived stigma. 
However, our insight into the nature strength of these relationships remains limited. In 
addition, research into specific forms of psychopathology was restricted to the study of 
anxiety and depression.
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It is a significant finding that none of the studies adopted a longitudinal design, therefore 
no conclusive evidence can be dawn from the research regarding causality. It therefore 
remains unclear whether perceived stigma contributes to the development of 
psychopathology, or whether the presence of mental health difficulties increases the 
likelihood for people to perceive themselves as being stigmatised.
The complex way in which variables (neuro-epilepsy, psychosocial, demographic and 
medication) are likely to interact with each other to cause psychopathology has not been 
adequately investigated. This may be a consequence of the limited number of studies 
which focused specifically on investigating the multi-etiological causes of 
psychopathology in epilepsy. Even amongst studies which accounted for a wide range of 
factors, there was variability amongst which factors were included. The learned 
helplessness model may be a useful way to conceptualise these relationships, but the 
evidence does not allow firm assumptions to be made. As stigma exists within a social 
context, it seems inevitable that other psychosocial factors will influence its association 
with psychopathology. Potential factors identified from the review which may be relevant 
include increased number of stressful events in the last year, poor adjustment to epilepsy, 
financial stress and an external locus of control.
None of the studies utilised standardized clinical diagnostic systems to measure 
psychopathology. The relationship between perceived stigma and clinically diagnosed 
levels of psychopathology has therefore not been investigated. In considering studies 
which investigated variables associated with psychopathology, the review highlighted 
some support for an association between perceived stigma and low self-esteem, epilepsy- 
related worries and negative feelings about life as a whole. Whilst these are not specific
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measures of psychopathology, they provide some insight into the mechanisms by which 
stigma and psychopathology may be related. However, limitations in design mean that 
causality between these relationships has not been established. One could hypothesise that 
perceived stigma may result in low-self esteem and therefore contribute to the development 
of depression. However it could also be hypothesised that someone with depression and 
low-self esteem may experience thinking biases that result in perceptions of stigmatisation. 
The studies in this review do not provide insight into answering these questions.
Many of the studies also contained a variety of methodological weaknesses, including 
sampling biases, thus limiting the generalizability of the results. Within the 13 studies 
reviewed, participants were sampled from over 10 different countries. Results from the 
only study to collect data from a wide range of countries, suggests cross-cultural 
differences between the way perceived stigma relates to other clinical and demographic 
variables [32], Jacoby et al. [36] suggest that this may be due to differences in 
sociocultural biases against epilepsy, healthcare systems, equal opportunity provisions and 
legal protections for people with epilepsy. These findings therefore highlight caution 
regarding the generalizability of results across different cultures. In conclusion, as 
proposed by Hermann and Whitman [4], this review highlights strong evidence to suggest 
an association between perceived stigma and psychopathology. However, further research 
is needed in order to gain a more comprehensive understanding of the nature of this 
association within the context of a Multietiologic Model.
Implications for future research
In over 20 years of research we still have a limited understanding regarding the role of 
perceived stigma in the development of psychopathology; and how this relationship
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interacts with other significant variables. Further research is required, using longitudinal 
studies, preferably with newly diagnosed patients. Future research in this area would also 
benefit from studies adopting sampling techniques aimed at reducing bias, in order to 
produce results that are more generalisable to the populations as a whole. Cultural 
differences will also need to be considered when interpreting results from different 
countries. Whilst the Multi-etiological Model refers to overall psychopathology, research 
investigating more specific disorders such as anxiety and depression are perhaps more 
clinically useful. A better understanding of the causes of psychopathology in people with 
epilepsy has important clinical implications; allowing for more informed approaches to 
prevention of psychopathology and the development of appropriate interventions in this 
population.
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Table 1: Possible Confounding Variables
(Hermann and Whitman, 1986 [4|1
Demographic Neuroepilepsy Psychosocial Medication
Variables Variables Variables Variables
Age Age at onset Fear of seizures Number of medications
Sex Seizure control Perceived discrimination Serum level
Race Duration of disorder Adjustment to epilepsy Medication type
Seizure type Locus of control Folic acid level
Multiple seizure types Life event changes
Etiology of epilepsy Social support
Type of aura Socio-economic status
Neuropsychological Childhood home
status environment
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Figure 1: The Search Process
^ r
62 papers were 
excluded by their title, 
leaving 83 papers.
52 papers excluded 
from their abstract, 
leaving 29 papers.
On reading the 
original papers, 5 of 
these were included.
46 of these were 
excluded based on the 
abstract, leaving 17 
papers.
Hand search of these 
journals revealed 47 
titles considered for 
inclusion
Of these, 42 were 
excluded based on the 
abstract, leaving 5 
papers.
On reading original 
papers, 21 of these 
were excluded, leaving 
8 papers.
On reading the 
original papers, none 
of the papers were 
included.
6 journals were noted 
to have contributed 3 
or more articles to the 
list of original papers 
checked.
Following a hand 
search of the 
references of these 31 
papers, 63 titles were 
considered for
inclusion.
217 papers 
obtained from the 
computerised search. 
Repeated titles were 
excluded, leaving 143 
papers.
were
13 papers were included in the final review.
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Katherine Bruce 
Supervisor: Professor Andrew Jahoda
Section of Psychological Medicine,
Division of Community Based Sciences,
Academic Centre,
University of Glasgow, Gartnaval Royal Hospital,
1055 Great Western Road,
Glasgow G1 OXH 
Tel: 0141 211 3927 
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TITLE
A qualitative investigation into the social experiences of young people with epilepsy;
perceived impact and sense of self
SUMMARY
Stigma has been found to have a significant impact on the lives of people with epilepsy. 
The stigma of epilepsy has been associated with low self-esteem, worry, negative feelings 
about life and depression (e.g. Westbrook et al. 1992, Jacoby et al. 1994, Baker et al. 1999 
and Lee et al. 2005). Whilst there has been much research conducted in this area, there has 
been relatively little focus on understanding the issues of stigma specific to adolescents. In 
a review of the literature Macleod et al (2003) conclude that ‘What we do not yet fully 
understand is how to capture the experience of stigma and the meaning of this experience 
to adolescents with epilepsy in a way that is sensitive enough to test hypotheses about 
stigma theory or correlate stigma to health outcomes like depression’. The current study 
therefore aims to use qualitative methods to explore the experiences and perceived impact 
of stigma in adolescents with epilepsy.
INTRODUCTION
Epilepsy has been historically associated with stigmatising responses from the general 
population, and research has demonstrated associations between the stigma of epilepsy and 
psychological distress (e.g. Westbrook et al. 1992, Jacoby et al. 1994, Baker et al. 1999 
and Lee et al. 2005). In defining the social phenomena of stigma, Goffman (1963) 
describes it as an ‘attribute that is deeply discrediting’ which can reduce a person ‘from a 
whole and usual person to a tainted, discounted one’. Goffman (1963) further observes 
stigma as the relationship between an ‘attribute and a stereotype’, therefore highlighting
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how people can be linked with socially undesirable characteristics when they are seen to 
have a discrediting attribute such as epilepsy. In the case of epilepsy, it may not be 
immediately apparent that the person is different, therefore allowing the person with 
epilepsy to choose who, when and what they disclose to others about their condition. This 
is complicated by the fact that such anonymity may be threatened through the event of a 
public seizure. Scambler and Hopkins (1986) therefore suggest that the effects of stigma in 
people with epilepsy may be experienced in two ways; via enacted and felt stigma. Enacted 
stigma refers non-legitimate discrimination such as teasing, and felt stigma refers to the 
fear of enacted stigma and feelings of shame associated with being epileptic. Felt stigma 
may therefore occur even if the person’s condition remains undisclosed, as they attach 
undesirable characteristics to themselves, resulting in a negative impact on self-identity. 
Whilst some studies have found that more than 60% of their participants did not feel 
stigmatised by their epilepsy (e.g. Westbrook et al. 1992 and Buck et al 1997), it is still a 
significant problem for many people.
The negative impact of stigma in the lives of adolescents with epilepsy has also been 
identified by research. Austin et al (2004) developed an instrument to measure stigma in 
children with epilepsy, and identified that higher scores of perceived stigma were 
correlated with more negative attitude, greater worry, poorer self-concept, and more 
symptoms of depression. In a study by Westbrook et al (1992), they found that adolescents 
with epilepsy who felt stigmatised reported low self-esteem more than those who did not 
feel stigmatised. Research exploring the stigma of epilepsy has mainly focused on adult 
populations, but it cannot be assumed that children and adolescents experience stigma via 
the same processes. Adolescence is acknowledged as a critical time for the development of 
self-identity and the formation of peer relationships, therefore stigma during this period
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may disrupt such processes and have detrimental effects on psychosocial health and self­
esteem (Abraham et al. 1999). The disruption of relationships with peers, and self­
perceptions of being different are therefore possible mechanisms by which adolescents 
with epilepsy may be negatively impacted by stigma, but these processes are not yet fully 
understood.
As part of the Glasgow Epilepsy Outcome Scales (Espie et al. 2001; Watkins et al 2006), 
the Glasgow Epilepsy Outcome Scale for Adolescents (GEOS-AD) was developed in order 
to measure the impact of epilepsy on quality of life in adolescents (Townsend, 2004). The 
scale was developed using qualitative data collected from adolescents with epilepsy, and 
was based on a conceptual model in which it is proposed that good quality of life requires 
that adolescents successfully adjust to having epilepsy, both in terms of illness-related 
factors and in identity formation (McEwen et al. 2004). To establish concurrent validity, 
Townsend (2004) conducted inter-correlations between the subscales of the GEOS-AD and 
the subscales of another quality of life measure (QOLIE-AD; Cramer, 1999). The GEOS- 
AD does not contain a specific subscale pertaining to measure stigma, however the 
strongest correlations were found between the QOLIE-AD subscale “Stigma” and the 
GEOS-AD subscales (r=0.246 to 0.583). Therefore, whilst the GEOS-AD appears to 
measure stigma, this was not a theme explicitly identified from within the focus groups. 
McEwen et al (2004) however, found that disclosure of epilepsy to their peer group was 
perceived as being a ‘particularly difficult and complex issue’, and in reference to the work 
of Scambler and Hopkins (1986), this may be viewed as an indication of felt stigma. The 
study’s focus on quality of life may therefore have prevented the subtleties of stigma 
theory being specifically acknowledged within data analysis.
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Following from the research of McEwen et al (2004) and Townsend (2004), the current 
study therefore attempts to focus specifically on the experiences of stigma in adolescents 
with epilepsy. MacLeod et al. (2003) in their review of the literature state that although 
research shows that stigma is an important factor in the health-related quality of life of 
adolescents with epilepsy, we do not yet know how to capture the experience and meaning 
of stigma to adolescents. They advise that qualitative research methods may be better 
suited to uncovering these experiences, ‘as the concept of stigma may not be blatantly 
obvious’. Whilst there are qualitative studies which describe adolescent’s personal 
accounts of stigma, these are within studies exploring the general effects of epilepsy, and 
do not focus specifically on stigma (e.g. Elliot et al., 2005 and Wilde et al., 1996). It is 
therefore proposed that the present study shall focus on exploring the experiences of 
stigma by adolescents with epilepsy, using qualitative techniques. Data shall be analysed 
via Interpretative Phenomenological Analysis (IPA), a method commonly used in health 
psychology research (Smith et al, 1999).
One could hypothesise that age-related differences may exist amongst adolescents, for 
example stigma may be a more salient issue in the lives of older adolescents, in terms of 
their future goals and being more aware of the perceptions of their peers. However, 
McEwan et al’s (2004) study into quality of life in adolescents with epilepsy found that, 
within their sample, there were no age-related differences between the issues raised. It 
would be interesting to identify whether these results would be replicated within a study 
focused specifically on stigma, therefore age-related differences shall also be explored. In 
order to aim for a more comprehensive picture of stigma in adolescents with epilepsy, 
participants shall not be excluded on the basis of having a mild/moderate learning 
disability.
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AIMS AND OBJECTIVES 
Aims
The aim of this study is to explore and describe the social experiences of adolescents with 
epilepsy, with a specific focus on stigma. The following objectives shall be explored in 
relation to different stages during adolescence, by looking separately at the experiences of 
participants within early and late adolescence.
Objectives
1) To describe experiences of stigma in adolescents with epilepsy.
2) To describe and explore the perceived impact of stigma in the lives of adolescents 
with epilepsy.
3) To describe and explore coping strategies for dealing with stigma.
PLAN OF INVESTIGATION 
Participants and Recruitment
It is anticipated that participants will be recruited from the Fraser of Allander 
Neurosciences Unit at the Royal Hospital for Sick Children, Glasgow and from Dr. 
Brodie’s clinic at the Epilepsy Unit within the Western Infirmary, Glasgow.
Data collection shall be based on purposive sampling. Participants will be included in the 
study if they a) are aged above 12 years 0 months and under 18 years 0 months b) have a 
diagnosis of epilepsy c) have had epilepsy for at least 6 months duration d) have had 
experience of at least one seizure in the past year and e) are able recall and provide a verbal 
account of recent events in their lives. Participants will be excluded from the study if they
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a) have deteriorating neurological health and/or b) have established non-epileptic seizure 
disorder as the primary clinical problem c) have a severe learning disability.
The following socio-demographic and epilepsy data will be obtained in order to enable a 
description of participants: date of birth, gender, postcode, seizure type, seizure frequency, 
medication and date of diagnosis. This information is essential for situating the sample, as 
Henwood and Pidgeon (1992) state it is important for the readers ‘to explore the extent to 
which the study may, or may not, have applicability beyond the specific context within 
which the data were generated’. Data shall be stored or a computerised database, and 
anonymised to ensure confidentiality.
In order to identify whether stigma has a different impact at specific stages of adolescence, 
participants shall be recruited into two groups; early adolescents (between 12years 0 
months and 15 years 0 months) and late adolescents (between 15 years 0 months and 18 
years 0 months). As this is a qualitative study, the number of participants required cannot 
be predetermined, therefore data collection should continue until thematic saturation is 
reached in each of the groups. However, as acknowledged by Willig (2002) ‘theoretical 
saturation functions as a goal rather than a reality’, as modifications of categories or 
changes in perspectives are always possible. Turpin et al (1997) proposed guidelines for 
qualitative research submitted as DClin Psy theses, and suggested that a sample of between 
eight and twenty participants is desirable.
Measures
The main method of data collection will be from an in-depth semi-structured interview 
with each adolescent. In their review of the literature on stigma in the lives of adolescents
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with epilepsy, MacLeod and Austin (2003) advise that ‘qualitative research methods may 
be better suited to uncovering the subtleties and complexities of how adolescents with 
epilepsy experience stigma and how it affects their lives’. They suggest that using open- 
ended questions may allow the adolescents more freedom to describe situations where they 
felt different, rather than direct questioning specifically about stigma.
Weber et al. (1994) highlight that adolescence poses some distinct challenges to the 
interview process. Building rapport and facilitating communication will therefore be given 
careful consideration when planning the format and conduct of the interviews. Greig et al 
(1999) acknowledges that in interviewing children, the use of a familiar setting and 
materials (e.g. drawings, games, exercises) are valuable in assisting motivation and 
reducing anxiety. The proposed study will give consideration to an appropriate ice-breaker 
game, and the interviews shall be piloted on approximately 4 adolescents to facilitate the 
development of a suitable approach.
Design and Procedures
Adolescents identified as meeting the inclusion criteria will be invited by post to 
participate in the study. Those adolescent interested in participating will be sent written 
information about the study and invited to complete and return a consent form. A separate 
information sheet and consent form will also be sent to the parents or guardians of 
adolescents under 16 years old.
Each participant shall be audio-taped during a one-hour semi-structured interview. It may 
be necessary to invite some adolescents back for a follow-up interview, if it was not 
possible to finish the interview within the allocated hour. Adolescents shall be interviewed
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within a comfortable environment, and ideally at a location familiar to them, for example, 
participants recruited from The Royal Hospital for Sick Children will be interviewed 
within The Royal Hospital for Sick Children.
IPA shall be used to analyse the data, as this is an approach which ‘aims to gain an 
understanding of how participants view and experience their world’ (Willig, 2002). It is a 
method commonly used within health psychology research (Smith et al 1999); and has 
been used to investigate experiences of stigma in people with schizophrenia (Knight et al 
2003). IPA may be criticised by Discourse Analysts, for its attempts to map verbal reports 
onto underlying cognitions. Smith (1999) responds to this by acknowledging that whilst a 
person’s thoughts are not transparently available from interview transcripts, EPA ‘engages 
in the analytic process in order to, hopefully, be able to say something about that thinking’. 
In contrast to Grounded Theory, IPA accepts that the results of analysis are a product of 
interpretation; therefore it does not deny the influence of the researcher on analysis. In 
preparation for this study the current author has become familiar with the stigma literature, 
therefore in order not to disregard the influence this may have on analysis, IPA has been 
chosen as an appropriate approach. Whilst a line-by-line analysis will not be used within 
this study, the analysis of data shall adopt a systematic process following procedures 
described in detail within the research literature (Smith et al. 1999; Willig. 2002). This will 
involve data being transcribed and thematically coded in order to identify central themes 
from individual interviews. The computer programme QSR NUD*IST 4.0 for Microsoft 
Windows will be used to facilitate this analysis (Microsoft. 1997).
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Settings and Equipment
It is anticipated that it will be possible for interviews to take place at the Epilepsy Unit at 
the Western Infirmary, Glasgow and the Fraser of Allander Neurosciences Unit at the 
Royal Hospital for Sick Children, Glasgow. Participants will be offered travelled expenses 
from their home address to the interview location. A tape recorder, microphone and blank 
tapes will be required to audiotape individual interviews, and in order to aid the 
transcription process a transcription machine will be required.
Data Analysis
Audiotaped recordings of interviews will be transcribed onto a word processing package. 
Data shall then be analysed within four stages, as outline by Willig (2002), and assisted by 
the computer package QSR NUD*IST 4.0. The initial process of analysis will involve 
reading each transcript several times, and making notes on statements which appear 
particularly relevant to what is important for each adolescent’s understanding and 
experiences of stigma. Willig (2002) describes this as ‘simply a way of documenting issues 
that come up for the researcher upon his or her initial encounter with the text’. Within the 
second stage, themes which emerge from the text will be identified. In stage three, these 
themes will be considered in relation to each other through the formation of clusters, in 
order to introduce structure within the analysis. Willig (2002) highlights ‘it is important to 
ensure that clustering of themes identified at this stage make sense in relation to the 
original data’, therefore the original text will be continually referred to when looking at 
themes. Within the fourth stage of analysis a summary table of structured themes will be 
produced, including quotations relating to each theme. To check for validity, another 
researcher familiar with IPA shall read one third of the transcripts alongside the identified 
themes. Smith (1996) describes this task as ‘ensuring the final report is a credible one in
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terms of the data collected and that a logical progression runs through the chain of 
evidence’. It is acknowledged that this is not a test of inter-rater reliability, but an attempt 
to validate the interpretation of the main researcher. Throughout the study guidance will be 
sought from researchers experienced in IPA analysis.
PRACTICAL APPLICATIONS
The study aims to describe the experiences of stigma in adolescents with epilepsy. By 
contributing to the research in this area, it is hoped this study will help to develop our 
understanding of stigma in the lives of adolescents with epilepsy. MacLeod et al. (2003), in 
their review of the literature, make specific recommendations for the need for further 
qualitative research within this area. By attempting to improve our understanding of the 
mechanisms by which stigma effects adolescents with epilepsy, this knowledge may then 
be used to assist clinicians and families in finding ways to reduce or prevent any negative 
impact on well-being. If appropriate support can be provided during adolescence, this may 
then help to reduce the likelihood of difficulties persisting into adulthood. In addition to 
the existing Glasgow Epilepsy Outcome Scales, the data from the current study may 
subsequently be used for the development of a scale specific to measuring the impact of 
stigma in adolescents with epilepsy. The measure of stigma developed by Austin et al 
(2004) was based on data collected from American children aged 9 to 14, therefore data 
from the current study could support the development of a scale which is more similar in 
situation and age-range to the GEOS-AD.
TIMESCALE
Ethical approval will be sought in June/July 2006. Following this, the semi-structured 
interview schedule will be piloted and evaluated. A review of the databases will commence
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in July 2006. Recruitment of participants will begin between July and August 2006. Data 
collection will commence in September 2006 and continue until March 2007. Data analysis 
will be ongoing, and the write up will take place between the months of May and July
2007.
ETHICAL APPROVAL
Ethical approval will be sought from NHS Greater Glasgow Primary Care Division, NHS 
Greater Glasgow Yorkhill Division and NHS North Glasgow University Hospital Division.
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AMENDMENTS TO PROPOSAL
The original design proposed recruiting two samples of participants, in order to look 
separately at issues relevant to young people within early and late adolescence. On further 
consideration it was felt that this design was not necessary, as a developmental perspective 
would be acquired through participants reflecting on both their current and past 
experiences. In addition, it was felt that the proposed design would result in a comparative 
study, which should not be the function of IPA methodology. Within the inclusion criteria, 
the original proposal stated that participants should have experienced at least one seizure in 
the past year. This was subsequently amended to include participants who had experienced 
at least one seizure in the past two years. Widening the inclusion criteria had practical 
advantages for recruitment, whilst still producing a sample of young people who had 
experienced seizures in recent memory.
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ABSTRACT
Background: Stigma has been found to have a significant impact on the lives of people 
with epilepsy. Research in this area has primarily focused on adult populations, resulting in 
a limited understanding of young people’s experiences of stigma. The current study 
therefore aims to use qualitative methods to explore the experiences and perceived impact 
of stigma in adolescents with epilepsy.
Method: Semi-structured interviews were carried out with nine adolescents aged between 
12 years 11 months and 17 years 10 months, in order to explore their social experiences of 
living with epilepsy.
Results: Data were analysed using Interpretative Phenomenological Analysis, with five 
superordinate themes emerging from the data. They highlighted the unique social 
limitations faced by young people with epilepsy and the pro-active ways in which young 
people responded to them. Whilst participants reported that other people’s responses were 
mainly positive, three of the young people described being teased and bullied. The 
disclosure of epilepsy emerged as a significant theme, and was related to fear of 
discrimination.
Conclusions: Participants had experienced stigma at school. Felt stigma was also shown 
through participants’ reports of embarrassment and fear of discrimination. The results 
highlight the important role of educational establishments in supporting young people with 
epilepsy, through collaboration with families and health services.
Keywords: Adolescence, epilepsy, stigma, social experiences, qualitative
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INTRODUCTION
Epilepsy has been historically associated with stigmatising responses from the general 
population, and research has demonstrated associations between the stigma of epilepsy and 
psychological distress [1] [2] [3], In defining the social phenomena of stigma, Goffman 
(1963) [4] describes it as an ‘attribute that is deeply discrediting’ which can reduce a 
person ‘from a whole and usual person to a tainted, discounted one’. Goffman further 
observes stigma as the relationship between an ‘attribute and a stereotype’, therefore 
highlighting how people can be linked with socially undesirable characteristics when they 
are seen to have a discrediting attribute such as epilepsy. In the case of epilepsy, it may 
not be immediately apparent that the person is different, therefore allowing the person with 
epilepsy to choose who, when and what they disclose to others about their condition. This 
is complicated by the fact that such anonymity may be threatened through the event of a 
public seizure. It has been proposed that the effects of stigma in people with epilepsy may 
be experienced in two ways; via enacted and felt stigma [5]. Enacted stigma refers non­
legitimate discrimination such as teasing, and felt stigma refers to the fear of enacted 
stigma and feelings of shame associated with being epileptic. Felt stigma may therefore 
occur even if the person’s condition remains undisclosed, as they attach undesirable 
characteristics to themselves, resulting in a negative impact on self-identity. Whilst some 
studies have found that more than 60% of their participants did not feel stigmatised by 
their epilepsy [1] [6], it still presents as a significant problem for many people.
The negative impact of stigma in the lives of adolescents with epilepsy has also been 
identified by research. Austin et al [7] developed an instrument to measure stigma in 
children with epilepsy, and identified that higher scores of perceived stigma were 
correlated with more negative attitudes, greater worry, poorer self-concept, and more
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symptoms of depression. In another study, adolescents with epilepsy who felt stigmatised 
reported lower self-esteem than those who did not feel stigmatised [1], Research exploring 
the stigma of epilepsy has mainly focused on adult populations, but it cannot be assumed 
that children and adolescents experience stigma via the same processes. Adolescence is 
acknowledged as a critical time for the development of self-identity and the formation of 
peer relationships, therefore stigma during this period may disrupt such processes and have 
detrimental effects on psychosocial health and self-esteem [8], The disruption of 
relationships with peers, and self-perceptions of being different are therefore possible 
mechanisms by which adolescents with epilepsy may be negatively impacted by stigma, 
but these processes are not yet fully understood.
As part of the Glasgow Epilepsy Outcome Scales [9] [10], the Glasgow Epilepsy Outcome 
Scale for Adolescents (GEOS-AD) was developed in order to measure the impact of 
epilepsy on quality of life in adolescents [11]. The scale was developed using qualitative 
data collected from adolescents with epilepsy, and was based on a conceptual model which 
proposes that good quality of life requires adolescents to successfully adjust to having 
epilepsy, both in terms of illness-related factors and in identity formation [12], To establish 
concurrent validity, they conducted inter-correlations between the subscales of the GEOS- 
AD and the subscales of another quality of life measure (QOLIE-AD [13]). The GEOS- 
AD does not contain a specific subscale pertaining to measure stigma, however the 
strongest correlations were found between the QOLIE-AD subscale ‘Stigma’ and the 
GEOS-AD subscales (r=0.246 to 0.583). Therefore, whilst the GEOS-AD appears to 
measure stigma, this was not a theme explicitly identified from within the focus groups. 
However, the focus groups did identify that disclosure of epilepsy to their peer group was 
perceived as being a ‘particularly difficult and complex issue’ [12], which may be viewed
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as an indication of felt stigma. The study’s focus on quality of life may therefore have 
prevented the subtleties of stigma theory being specifically acknowledged within data 
analysis.
Following from the previous research with Scottish adolescents [11] [12], the current study 
therefore attempts to focus specifically on the experiences of stigma in adolescents with 
epilepsy. MacLeod et al.[14] in their review of the literature state that whilst research 
shows that stigma is an important factor in the health-related quality of life, we do not yet 
know how to capture the experience and meaning of stigma to adolescents. MacLeod et al. 
advise that qualitative research methods may be better suited to uncovering these 
experiences, ‘as the concept of stigma may not be blatantly obvious’ [14]. Whilst there are 
qualitative studies which describe adolescents’ personal accounts of stigma, these are 
within studies exploring the general effects of epilepsy, and do not focus specifically on 
stigma [15] [16], It is therefore proposed that the present study shall focus on exploring the 
experiences of stigma by adolescents with epilepsy, using qualitative methods. In order to 
achieve a more comprehensive picture of stigma in adolescents with epilepsy, participants 
shall not be excluded on the basis of having a mild/moderate learning disability.
AIMS AND DESIGN
This study aimed to explore and describe the social impact of epilepsy on adolescents, with 
a specific focus on stigma. Utilizing a qualitative design, data were gathered through semi­
structured interviews and analysed using Interpretative Phenomenological Analysis (IPA). 
The specific aims of the study were:
1) To describe experiences of stigma in adolescents with epilepsy.
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2) To describe and explore the perceived impact of stigma in the lives of adolescents 
with epilepsy.
3) To describe and explore coping strategies for dealing with stigma.
IPA was chosen as an appropriate framework within which to analyse the data, as it is an 
approach which aims to gain an understanding of how participants view their personal and 
social world (Smith, 2003). It is a method which accepts that the results of analysis are a 
product of interpretation and is commonly used within health psychology research (Smith 
et al 1999). Quality criteria for qualitative research were considered in the design of the 
study, by referring to CASP (Critical Appraisal Skills Programme) guidelines [17].
METHODS
Participants
Following IPA methodology [18], the study attempted to recruit a homogeneous sample. 
Purposive sampling was therefore employed, with nine participants recruited from two 
specialist epilepsy centres in Scotland; the Fraser of Allander Neurosciences Unit at the 
Royal Hospital for Sick Children, Glasgow and the Epilepsy Unit at the Western Infirmary, 
Glasgow. The young people had all attended out-patient clinics within these services, 
where they were seen by professionals specialised in the assessment and intervention of 
epilepsy. Participants were included in the study if they a) were aged above 12 years 0 
months and under 18 years 0 months b) had a diagnosis of epilepsy c) had epilepsy for at 
least 6 months duration d) had experience of at least one seizure in the past two years and 
e) were able recall and provide a verbal account of recent events in their lives. Participants 
were excluded from the study if they a) had deteriorating neurological health and/or b) had 
established non-epileptic seizure disorder as the primary clinical problem c) had a severe
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learning disability. Therefore, participants who were able to talk and reflect upon their 
experiences of living with epilepsy were not excluded on the basis of having a learning 
disability. Like their adolescent peers, young people with epilepsy may also be living with 
additional difficulties which may impact on their social experiences. This may include a 
learning disability, mental health difficulty, motor-difflculty or specific learning difficulty. 
However, these young people share experiences unique to living with epilepsy and each 
have their individual contributions to add to our understanding of epilepsy. If the young 
person had something to say about being an adolescent living with epilepsy, we were 
interested in hearing their story. The study therefore attempted homogeneity through 
recruiting a sample of young people with active epilepsy whom had accessed specialist 
epilepsy services; whilst acknowledging the diversity which inevitably exists within this 
group.
The sample consisted of 9 adolescents (5 male, 4 female) between the ages of 12 years 11 
months and 17 years 10 months (mean age. 15 years 7 months). The sample characteristics 
are presented in Table 1. As highlighted in the table, all participants were on anti-epileptic 
medication, with four receiving polypharmacy. In addition, two participants had Vagus 
Nerve Stimulation systems implanted. Six participants experienced more than one type of 
seizure; seven experienced generalised seizures and eight experienced partial seizures. 
Seizure frequency within the sample was varied, ranging from daily seizures to less than 
one a year. The mean age of diagnosis within the sample was 7 years 10 months. Two 
participants had attended special needs schooling and both experienced frequent seizures.
Insert Table 1 here
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Clinicians within the respective epilepsy centres identified adolescents whom they 
considered met the study’s inclusion and exclusion criteria. Potential participants were 
posted information and invited to participate in the study (Appendix 3.1 contains 
information sent to participants). Individuals who were interested in taking part in the 
study completed an opt-in form, and were contacted to arrange an appointment to meet 
with the researcher. Adolescents with a learning disability or who were under 16 years of 
age also required parental consent to participate in the study. Informed consent was 
obtained prior to the interview being conducted (see Appendix 3.2) and participants were 
offered travel expenses. Participants gave consent for their clinicians to provide the 
researcher with clinical information about their seizure type, seizure frequency, medication 
and date of diagnosis. Full ethical approval was obtained from Greater Glasgow & Clyde 
NHS (see Appendix 3.3).
Sample size is not predetermined in qualitative research and recruitment continued until 
theoretical saturation had been achieved [19]. Therefore recruitment was discontinued 
when no new themes emerged from the final two participants. However, as acknowledged 
by Willig [19] ‘theoretical saturation functions as a goal rather than a reality’, as 
modifications of categories or changes in perspectives are always possible. In total, 66 
young people were invited to participate in the study. Of these, 13 agreed to participate, 
however 5 subsequently opted-out of being interviewed. This was due to reasons such as 
exam and work commitments, or the young person no longer being interested in taking part 
in the study.
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Procedure
Nine semi-structured interviews were conducted, each lasting approximately one hour. 
Interviews were recorded using a digital recording device and took place in rooms based at 
the clinics from which participants were recruited. It was arranged for one participant to 
be interviewed at their GP surgery, due to difficulty arranging travel to the hospital. Weber 
et al. [20] highlight that adolescence poses some distinct challenges to the interview 
process. Hence, building rapport and facilitating communication were given careful 
consideration when planning the format of the interviews. To aid the development of an 
appropriate interview procedure, trial interviews were conducted with two colleagues and 
one adolescent. In addition, the first three interviews were considered as pilots, allowing 
further reflection on the interview process. Interviews began with the completion of a 
poster about the main areas of the participant’s life; family, friends, school and interests. 
This was then referred to throughout the interview, helping the interviewer to prompt the 
participant to reflect on their experiences of living with epilepsy in different areas of their 
life. The use of visual materials has been found to be valuable in assisting motivation and 
reducing anxiety when interviewing young people [21]. It was anticipated that this format 
would aid communication, by encouraging the young person to begin talking about 
themself and prompt memories about their experiences during different times in their life. 
The interview schedule progressed developmentally through 1) experiences when first 
diagnosed 2) experiences growing-up 3) current experiences 4) future experiences. The 
schedule was constructed in-line with guidelines for semi-structured interviews in IPA [ 18] 
and functioned as a guide, with the aim of facilitating the participant to tell their own story 
and for the interviewer to explore novel areas. The structure of the interviews aimed to be 
broad and flexible, with general questions followed by prompts as necessary (see 
Appendix 3.4).
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Data Analysis
All interviews were transcribed verbatim, with personal identifiers removed. IPA was used 
as a framework for analysing interview transcripts; following step-by-step guides as 
detailed by Smith et al. [18] [22], A flowchart of the process of analysis is shown in 
Figurel. Transcripts were read by the researcher several times, in order to become familiar 
with the data. During this process notes were made in the left-hand margin, in order to 
highlight statements which appeared particularly relevant or interesting. In further 
readings, the titles of emerging themes from the text were identified and written in the 
right-hand margin. These themes were considered in relation to each other through the 
formation of clusters, which were given a title in order to represent superordinate themes. 
A summary table of structured themes was then produced, including quotations relating to 
each theme. This process was completed for each transcript, with later transcripts being 
oriented by earlier analyses. Similarly, earlier transcripts were re-read in light of new 
themes emerging from the analysis of later transcripts. During all stages of analysis 
transcripts were re-read and the original text was continually referred to in order to ensure 
that the themes were grounded in what was actually said. Analysis was therefore an 
evolving and circular process and sometimes resulted in themes being dropped. At the end 
of the analysis process, a final table of themes was constructed.
Insert Figure 1 here
Analysis of the first three transcripts was done under close supervision by the research 
supervisor. Smith et al. [18] refer to this as a mini-audit, whereby the supervisor checks the 
validity of initial annotations and the clarity of the system adopted. Following this process 
a researcher experienced in IPA conducted an independent audit on the first three 
interviews, to advise whether the analysis process was coherent and explicit. Once the final
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table of themes had been established, another researcher familiar with IPA read two of the 
transcripts alongside the identified themes. The outcome of these audits confirmed the 
appropriateness of connections made between the text and themes. Smith (1996) [23] 
describes these tasks as ensuring the final report is credible in terms of the data collected 
and that a logical progression runs through the chain of evidence. It is acknowledged that 
these are not a test of inter-rater reliability, but an attempt to validate the interpretation of 
the principle researcher.
RESULTS
Five superordinate themes emerged from the data relevant to participant’s social 
experiences of living with epilepsy and its impact. Table 2 displays the final table of 
themes and indicates the participants from whose transcripts they emerged. It should be 
recalled that interviews took a developmental approach therefore, the results reflect upon 
participants’ experiences within both childhood and adolescence. The following results are 
presented in five sections, and deal with each of the superordinate themes in turn. The 
different dimensions of superordinate themes are described, alongside selective quotes (see 
Appendix 3 .5 for a comprehensive table of illustrative quotes for each theme).
Insert Table 2 here
1) Limitations on Activities
The following superordinate theme concerns the way in which epilepsy can impact on 
participants’ social lives and activities. These experiences may set individuals with 
epilepsy apart from their peers and provide the basis for stigmatisation to occur. The nature 
of these limitations varied greatly amongst the young people. However, the extent to which
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participants perceived themselves as having ordinary lives appeared to be key to their 
sense of social difference, rather than the nature of the limitations themselves.
Restricted Independence
Participants described restrictions on their independence, as a consequence of living with 
epilepsy. Some participants referred to activities where they required supervision, due to 
the potential risks a seizure could have in those situations; for example whilst swimming or 
baby-sitting:
I: So what are the biggest things in your life that have changed because of it?
P02: Erm...Can’t do certain things with my niece, can’t baby-sit her. I can’t go and take her to the 
shops and that by myself. Just like daft things, but it’s quite a lot to you.....
Whilst acknowledging the necessity of supervision, this was perceived by some young 
people as being a negative restriction on their lives. There were also examples whereby the 
young person did not feel the supervision was justified and therefore felt over-restricted:
P02: Like when I was in the class and I wanted to go to the toilet, you’d to wait for somebody to 
come with you, and like...I can go myself...just things like that....I didn’t have any more privacy 
any more.
The strongest sense of restriction was felt from the young people with a learning disability, 
who appeared to have a greater dependency on others:
P06:1 am fed up that I cannot go out because I need someone beside me cos I get epilepsy and I just 
drop down.
I: So you’ve not been able to go to the cinema, as you’ve been growing up, on your own without an 
adult. What else haven’t you been able to do on your own?
P06: Basically everything
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For these young people, limited independence related to a sense of reduced autonomy and 
perceptions of being set-apart from their peer group.
Restricted activities
Many participants described either externally or self-imposed restrictions on their 
participation in a range of activities. Externally-imposed restrictions came from parents, 
doctors and providers of leisure activities. Some related to issues of safety and risk whilst 
others were enforced in an attempt to avoid triggering seizures:
P07: Actually one thing that really, really annoyed me....at the time I was playing for a football 
team and I was a striker, and I wasn’t too bad and I was getting better and better and then they told 
me I had to take a while out to see if headering the ball was effecting it...
Participants also described restricting their own activities, by avoiding situations which 
were more likely to trigger a seizure or in order to avoid experiencing a seizure in those 
situations. One person avoided competitive sports events as a consequence of an 
unpleasant seizure experience. Young people felt most strongly about restrictions in 
activities which they enjoyed, were skilled in or which offered opportunities for socialising 
with their friends:
P07: It has instructions, the rules, for the people that like do the paintballing, that say epileptics can’t 
come... so that annoyed me as well... when all my friends went for a birthday party and I couldn’t 
join them, because of my epilepsy.
Disruption of activities
The young people described a variety of experiences where their activities were disrupted 
as a consequence of having epilepsy. These included disruptions caused by seizure events
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or taking a break from physical activity to avoid a seizure being triggered. Most 
participants had the same range of social interests as their peers, but there was the potential 
for disruption due to having a seizure.
I: So what sort of stuff does it get in the way of then.. .if say you’re having a bad day?
P08: Anything...anything I happen to be doing at the time. I’m always dead distracted at the time, 
because I’m always thinking... am I going to be ok without having to go home, or am I going to 
have to go home and take some tablets or whatever.
There were also descriptions of existing hobbies being disrupted following the onset of 
epilepsy, through effecting their skills and performance:
P09: Just cos I was so bad at it, cos I was losing 16 nill and that, cos I just kept.. .the ball just kept 
going past me. Just couldn’t save anything, so I tried to go outfield and I was even worse, then I just 
kind of... was fed-up with it...
The participant described this as being a consequence of having epilepsy. However, it was 
not clear from their account whether this was due to the effects of seizure-activity or the 
side-effects of medication. Disruptions caused by seizures appeared more significant if 
they led to the young person feeling embarrassed:
P02: It was ages ago, it was like when I was having fits all the time, and I was in the shopping 
centre, and then I was looking at some of the clothes and then, I got a two second warning before a 
fit came on, and then I had a fit.
I: So you were in.. .where were you in? (I was in a shopping centre) yeh.
P02: And then...I can remember waking up and everybody’s staring at me...I felt embarrassed 
{ {participant laughed} }
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In the case of one participant who did not report embarrassment in the event of a public 
seizure, this appeared related to them not feeling socially defined by their epilepsy:
I: What’s like? Having a seizure in.. .cos that’s quite a public place I guess...
P06: Well because I’m so out of it I don’t really care what I look like. Later on I think.. .once again, 
I’m a really laid back person, I don’t really care, I don’t know anyone there, so...so it doesn’t 
matter, but you know if I did know anyone there I would be like ‘Who cares anyway?’. If it’s 
someone I don’t like, I don’t care, if it’s someone I do like, they won’t care, so I don’t care.
Minimal limitations
Some participants described the social impact of epilepsy as being minimal. One young 
person in particular did not feel their life had changed in any way following their diagnosis 
of epilepsy. It is noteworthy, that this young person did not experience frequent seizures, 
and was very selective about disclosing his epilepsy. Other participants acknowledged 
some social limitations, but perceived them as being minimal, with little impact on their 
life. In some cases this was influenced by their level of interest in the activities:
I: ...any other things at school which epilepsy - - you mentioned the... {{Referring to impact of 
epilepsy at school, participant previously stated that he stopped playing basketball}}
P08: Apart from the sports I suppose. I wasn’t really bothered about them to tell you the truth. They 
were just something I did in my spare time/oA^None of my friends do that either, so...I wasn’t 
really that bothered when I left.
2) Response to Epilepsy from Others
The way participants describe other people’s responses provided a valuable insight into the 
extent to which they felt stigmatised by having epilepsy. Reports of rejection and teasing 
were contrasted with experiences of support and acceptance. Only a minority of 
interactions were described as being negative.
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Teasing/Bullying
Three participants described being teased or bullied by peers within the school 
environment. These experiences ranged from teasing to being ignored and avoided by 
peers:
P02:1 get treated sometimes differently at college. Cos, a lot of the people they do say to me wee 
jokes about my epilepsy and they think its funny but I don’t, so...it’s pretty annoying.
I: Can you tell me what sort of things they say?
P02: Like they imitate me taking a fit and just like things like that.. .one falls on the ground and that 
and starts shouting, ‘oh I’m taking a fit, I’m taking a fit’, but it’s not really that funny....
These negative experiences were limited to specific people, and participants did not report 
being teased or bullied throughout their entire time in education. Teasing and bullying 
were therefore described as being the exception, in terms of other people’s responses to 
epilepsy. Peer avoidance and rejection was experienced by one participant during their 
time in mainstream primary school, which was in contrast to their subsequent experiences 
within special needs education.
Support
Participants made frequent reference to the provision of support from people who knew 
they had epilepsy; including family, friendship groups and teachers. This ranged from 
practical help with seizures to more psychological support, including concern for their 
well-being and encouragement to lead a frill life:
I: Where do you get the most support from?
P02: My friends.
I: In what way?
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P02: They do loads of stuff with me, and they don’t put my epilepsy as an excuse all the time.. .like 
they kid on that I don’t have it. ..so.. .that’s what I like
Participants were explicit in their preference for more supportive environments. For 
example some schools had put considerable effort into making sure the young person was 
looked after and comfortable when they had a seizure at school:
I: What are the teacher’s like generally? I don’t know, at {{Name of previous secondary school}} 
and at...
P07: They’re not too bad. They’re quite good up here. Yeh, they were good down there as well. But 
err - - in { {Name of previous school} }.. when I’d had a few fits, in the medical room, they bought 
a new bed and it had a side... a kinda of cushion side which hung down and you just bring it up 
around and push it into place so its nice and firm, so that I wouldn’t fall out of the bed and the 
medical room was right beside the office... and they had a part of the wall replaced with a window, 
so that if I felt a fit coming on I would just knock on the window and they would come through 
.. .but up here, it’s not so good. There’s a bed here, but its got no side, so I can’t really go up there 
and there is no way of me telling the office I’m going to have a fit, so they don’t know...so they 
often leave me either on the floor on top of some blankets or something.. .erm but I mean they won’t 
know I’m having a fit unless there is someone else in the medical room with me, which I find quite 
annoying.
Not a significant issue
The majority of participants did not perceive their epilepsy as being a significant issue to 
others, particularly within friendship groups. Epilepsy was not described as having a 
negative impact on existing friendships and many described it as being of little relevance:
I: I was just wondering what your friends and your classmates kind of made of you having epilepsy 
as you were growing up?
P05: Erm. - - They don’t really take much notice of it actually. It doesn’t really affect any things - - 
it doesn’t really have much relevance to be honest.
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These participants believed that their peers were not judgemental about their epilepsy, and 
either offered support and inclusion, or simply didn’t raise it as an issue.
Anxiety
Participants described others being worried about their well-being and anxious in response 
to seizure events. In some instances the young person perceived people as being over- 
worried, whilst others acknowledged that their worry was justified:
I: What are things like at school? I don’t know maybe in terms of how the teachers reacted to you?
P05: Urmm. They were always a bit, sort of too cautious. They kind of... I don’t know... exaggerated 
a little bit, which is kind of a bit annoying, but I don’t know, that’s it really...
I: Can you give me an example of what sort of stuff...
P05: I don’t know - - like if we went on school trips or anything everyone was always just constantly 
asking me like if I was alright and everything? Which was quite annoying, but?
Other people’s worry could cause some annoyance, but this anxiety was also able to 
demonstrate that people cared about them. Participants described others being 
apprehensive about the potential for seizures to occur and anxious responses from people 
witnessing seizures. There were accounts of people being terrified, shocked, screaming, 
panicked and not knowing what to do. In some instances this anxiety was viewed as being 
unhelpful:
I: The people that don’t understand How do they react then? The people that don’t really...
P07: Err - - scream for help... and just like before I go completely into the fit, I’ll maybe ask them to 
do something, maybe hold my head or something, make sure I don’t hit it off the ground, but they’ll 
just stand there looking at me - - and I’d think to myself... if I was that guy over there I’d punch him. 
But, err -  yeh it can be frustrating when I ask them to do something which can help me from hurting 
myself too much and they just stand there watching me (yeh?) rather than do anything about it.
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Anxious reactions were not limited to people who were unfamiliar with the young person’s 
diagnosis, as parents were also described as becoming panicked in response to seizures. 
However, in some cases people’s anxieties appeared to reduce once they had become 
familiar with seeing seizures.
3) Potential Negative Impacts
The following cluster of themes highlighted awareness of the potential ways in which 
epilepsy could negatively impact on their social world. These themes all highlight a sense 
of uncertainly about the future.
Discrimination
One young person feared epilepsy would provide people with the ammunition to bully 
them, which was in the context of knowing that people get bullied and teased for things 
less significant than epilepsy:
P03: ...everyone takes the piss out of everyone for the slightest reason.
I: Right ok, so epilepsy would be...
P03. Err... something that I’d never be able to live down.
Fear of being bullied influenced participants’ choices around disclosing their diagnosis to 
others. One participant referred to her parent’s fears that others would not perceive her as 
being clever due to having epilepsy. However she believed that the potential for 
discrimination would only be from people that did not know her, as people she knew 
would judge her by the abilities she demonstrated:
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P06: I never thought of it until dad like mentioned it, but that’s people that don’t really know me. 
People at school know I am pretty bright I’ve had quite a few pretty good praise like from teachers, 
so I don’t really...so I don’t really care if people I don’t know think I’m dumb, again erm...just 
people in school know I’m not dumb and people in school don’t really care about my epilepsy so... 
they think “oh she’s smart” - - epilepsy is nothing to do with it anyway.
Some young people were also aware that they may face difficulties around employment, 
due to the risk of them having seizures. However, in the case of one participant who feared 
they may be discriminated by their work, their fears were not realised after disclosing their 
diagnosis to their employer.
Risk of seizure-related death
Participants acknowledged that seizures could be potentially dangerous in certain 
situations, and that they faced greater risks than their non-epileptic peers. One young 
person who saw someone die during a seizure event, had become anxious that it could 
happen to her. Although no-one said that they avoided activities due to the risk of death or 
fatal accident, they acknowledged the need for extra supervision in places like swimming 
pools.
Future limitations
Participants were aware that epilepsy would have an impact on their adult lives. They 
knew that there could be lifestyle restrictions, including not being permitted to drive and 
the risks associated with living in accommodation independently. Yet there remained 
uncertainty about the extent to which epilepsy would impact on their lives, as this was 
dependent upon how their condition progressed regarding seizure severity.
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4) Disclosure of Epilepsy to Others
Approaches to disclosure reflected participants own feelings about having epilepsy and 
their perceptions of how other people would respond to the diagnosis. All of the 
participants had disclosed their condition to at least some of their peers; however this was 
done with varying degrees of comfort.
Selective disclosure
Decisions around disclosure were raised as a significant issue, with participants being 
selective about whom they told. Participants often chose to disclose their diagnosis to close 
friends, with trustworthiness highlighted as an important consideration when choosing who 
tell:
I. How many people is that that you’ve told then, that are close?
P03: Two.
I: And what makes them trustworthy? What makes you be able to trust them?
P03: Well erm.. .one of them I’ve known since primary and erm... another one, basically, she stays 
far away, so she’ll never get to see my friends.
Choosing to tell people who could be trusted not to disclose their diagnosis to others, was a 
protective response to the fear of being teased. In addition, one participant described being 
selective about disclosure because they felt embarrassed about having epilepsy:
I: Why did you decide not to tell them?
P05: Erm - - 1 don’t know, I think I just found it quite embarrassing to be honest
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Comfortable with disclosure
A range of participants described being comfortable about disclosing their epilepsy to 
others and made no attempt to conceal it. For one young person, the fact that they attended 
a special needs school appeared to eliminate the issue of disclosure:
I: And did you tell him that you had epilepsy, or did someone else tell him?
P01: Well they know. There is a reason for why they do these schools you know. {1st School}’s a 
special needs school, the (2nd School}’s a mixture and {current school}’s a special needs school. 
So, I’d be in the section of special needs in the {2nd School}, so {friend 3} would have known yes, 
or he would have found out Somebody told him. Or maybe I would have told him. I probably told 
him.
I: If you were to make a new friend, would you probably tell them you have epilepsy (yes) - - Would 
that be easy to do?
P01:Erm, - - yes. I’d just tell them.
One young person suggested it was easier to talk about their epilepsy with others who had 
a disability. This suggests that there may be a benefit to mutual disclosure. Participants 
described disclosing their epilepsy when it came up in conversation or as an explanation to 
a seizure event. Some participants did not feel they had a choice about concealing their 
diagnosis, and talked about disclosure as something that just needed to be done:
P02:...there’s no point hiding it cos they’ll find out sooner or later. Just in case you take a fit in 
front of them. So... .might as well just tell them...
Young people who appeared to be most comfortable about disclosing their epilepsy also 
appeared to be the least embarrassed about their diagnosis:
P08: I’ve got no problem hiding it, I mean I don’t need to hide it. I’ve never hidden it from anybody 
actually...erm...its always something I can admit to... Not really a problem.
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5) Pro-active Responses to Social Impact
Participants described how they dealt with the social impact of living with epilepsy, and 
their ability to reduce social difference through seeking to lead a ‘normal life’.
Getting on with life
In response to the disruption of activities and risk to safety, participants described an 
attitude of getting on with life, thus reducing the impact of epilepsy. For some participants 
that involved accepting risk and ignoring their worries:
P05:1 love skiing.
I: And your epilepsy... does that limit that in any way?
P05: No - - well I do - - I sometimes do get quite worried, but I would rather ski than not ski, so... 
(ok) - - So I just sort of forget about it.
Whilst this could conflict with other people’s concerns for their safety, there were also 
instances where they were encouraged not to let epilepsy interfere with their social 
activities:
P02:1 told my dance teacher and then she said ‘don’t let it effect your dancing’, so I just didn’t...I 
just got on with my dancing as usual.
In some instances this involved making adaptations to their lives, for example by taking 
rests during activities or developing new interests:
P09:1 was kind of gutted about football, erm, but then I tried to think, tried to find other sports I was 
good ai..(ok) I found skateboarding for a while, but then.. .1 couldn’t improve and I hit myself in the 
face with a skateboard once (oh dear) But then I found golf and that was pretty good.
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Confront teasing
In response to being teased about epilepsy, participants spoke about confronting the people 
who were teasing them. This highlighted their belief that it was not acceptable for them to 
be treated that way and they felt empowered to say this to people. One young person 
reported that he had never been teased, but described that his reaction would be to fight 
back:
P07: But no, no-one’s teased me (that's great) - - I’d have them if they did (yeh?) Yeh - - 1 mean I 
don’t often get in fights and that, but if someone were to tease me about something that I have to put 
up with, and I’ve got to put up with, like throughout my life, or so it has been for four years, I 
wouldn’t be so happy.
DISCUSSION
In exploring the social experiences of young people with epilepsy, the results highlight 
some distinct social challenges associated to living with seizures. The impact of these 
varied dramatically and in some cases appeared to be influenced by the presence of a 
learning disability and frequency of seizures. Amongst participants there was a strong 
sense of resilience, demonstrated through an attempt to limit the impact epilepsy could 
potentially have on their lives. The participants sought a sense of normality in their lives 
and attempted to reduce the distinctions between themselves and their peers. Few people 
reported experiencing negative responses from others towards their epilepsy, with most of 
the young people feeling accepted and supported.
Scrambler and Hopkins [5] definition of enacted stigma refers non-legitimate 
discrimination, which was highlighted within the current study in the form of bullying and
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teasing. However, it is noteworthy that these experiences were limited to peer responses 
within the school/college environment. This was consistent with other studies which found 
the majority of their subjects did not feel they were stigmatised by their epilepsy [1] [2] , In 
general, limitations due to seizure activity and risk were of greater significance than 
restrictions based on discrimination.
As suggested by stigma theory, people may still feel stigmatised even in the absence of 
directly experiencing discrimination or social rejection. This is described as felt stigma, 
which can be related to the shame associated with having epilepsy or the fear of enacted 
stigma [24], Evidence of felt stigma was identified through accounts of young people 
feeling embarrassed by their epilepsy. Felt stigma was also apparent through participants’ 
fears that they might be bullied or discriminated against in employment. There was also 
evidence that the way some young people managed disclosure of their epilepsy indicated 
their sensitivity to the stigma associated with epilepsy. Selective disclosure emerged as a 
theme, and is a concept referred to by Goffman [4], who talks of people disclosing their 
epilepsy to ‘sympathetic others’. In these cases the participants’ fear of teasing resulted in 
careful consideration regarding who could be trusted not to tell others about their illness. It 
is interesting that the young person who felt their epilepsy had the least social 
consequences on their life, was also the most selective in terms of disclosing his diagnosis 
to others. He talked about his uncertainty of how peers would react if they saw him having 
a seizure and fear of being bullied if people knew of his diagnosis. Therefore whilst the 
social burden of epilepsy was low, in many respects the psychological burden of his felt 
stigma was greater. Issues of felt stigma are an important consideration for adolescents 
with epilepsy, given the potential impact on self-perceptions and identity formation.
I l l
Felt stigma was not evident in all participants, as some spoke of not being embarrassed by 
their epilepsy and comfortable about disclosing their diagnosis to others. There was also a 
widespread feeling of positive acceptance regarding other people’s responses to disclosure, 
with the majority of people being either supportive or indifferent.
Accounts of other people’s anxious emotions to their epilepsy, was another issue raised by 
participants. Albrecht et al. [25] identified that ambiguity in social interactions was the 
most frequent reason for people distancing themselves from a stigmatized person. 
Scambler [24] highlights that in response to people with epilepsy, this may be due to the 
unpredictability, the drama or a fear of coping. Although, the reasons for other people’s 
anxieties cannot be inferred from the participants’ accounts, the impact of these responses 
appeared limited to the annoyance of people over-worrying or being unhelpful around 
seizures. Link and Phelan [26] theorize that personal contact can reduce stigmatisation 
through humanising the condition. This is able to help ensure the stigmatised person is 
seen as an individual and not an illness. As none of the participants described losing 
existing friends as a result of disclosure, this may provide some support for this theory. 
This concept was highlighted by one participant in particular, who believed she was not 
defined by epilepsy amongst her friends, but acknowledged that strangers may form 
judgements in reaction to the diagnosis.
In addition to stigma theory, other researchers may have put a greater emphasis on other 
theoretical perspectives when reflecting upon the themes which emerged from this study; 
for example through focusing on resilience or social identity theory. Many of the young 
people appeared to demonstrate resilience through their accounts of positive adaptations to 
living with epilepsy. Research in resilience development has proposed three main
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influential factors 1) individual attributes of the young person themselves, 2) aspects of 
their families, and 3) characteristics of their wider social environments [27], These factors 
were evident within the present study, particularly through descriptions of supportive, 
encouraging and accepting responses from other people; including family, friends, teachers 
and peers. Social identity theory also provides a useful perspective for conceptualising the 
current data; which proposes that individuals strive to maintain a positive self-image, both 
in terms of personal and social identity (Tafjel, 1978) [28], Personal identity includes 
specific individual attributes such as competence, talent and sociability, whilst social 
identity refers to the part of a self-concept which derives from group membership and the 
value of emotional significance attached to that membership [29], The theme of 
‘teasing/bulling’ may be the consequence of others attempting to enhance their own self- 
concept, through being hostile against those categorised as having epilepsy. Further, the 
salience of participants’ personal and social identities in relation to epilepsy was also 
apparent within the interviews, and undoubtedly impacted upon their behaviour. Many of 
the accounts suggested a strong sense of personal identity and for one participant in 
particular was notably protective against the potential stereotypes attributed to having 
epilepsy. Some participants also talked in a way which suggested they had a stronger sense 
of social identity towards their friendship groups than within an ‘epilepsy group’ which 
may have been a strategy employed to promote their own resilience.
In conclusion, whilst the interviews did not explicitly ask participants whether they felt 
stigmatised, the detailed accounts provided by the young people suggest that the majority 
did not. Despite this, there was some evidence of enacted and felt stigma which did have 
an impact on the young people’s lives. However, what resonated from the majority of 
interviews was a sense of resilience in response to the unique social challenges they faced.
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Implications for Practice
The finding that all experiences of enacted stigma took place within the school 
environment, suggests that schools have a significant responsibility in supporting young 
people with epilepsy and changing the attitudes of young people’s peers. Education is 
regarded as the best method of reducing stigma, through eliminating fear of the unknown. 
Therefore first aid training and education may be valuable in reducing this fear. Strong 
links between families, health services and educational establishments may help to produce 
the most appropriate balance of support for the young person. This will involve being 
mindful of the young person’s changing needs throughout the various stages of their 
development.
The young people were pro-active in reducing the impact of epilepsy on their lives, in an 
attempt to lead similar lives to their peers. Whilst being mindful of the risks, encouraging 
young people to find ways to adapt to living with epilepsy were identified as important. In 
addition, despite the impact of epilepsy on adulthood being potentially unclear, young 
people may still benefit exploring any worries they may have in relation to the future.
Implications for Future Research
This study focused on a specific population of young people with epilepsy; they were on 
anti-epileptic medication and had experienced at least one seizure in the past two years. 
Further research could explore experiences of young people in a sample with well- 
controlled epilepsy, who are no longer experiencing seizures. As identified in the study, 
young people with infrequent seizures demonstrated signs of felt stigma as well as those 
with frequent seizures. In addition to the existing Glasgow Epilepsy Outcome Scales, the
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data from the current study may potentially be used to guide the development of a scale 
specific to measuring the impact of stigma in adolescents with epilepsy in a Scottish 
population. Whilst similar themes emerged amongst young people regardless of whether 
they had a learning disability, there appeared to be some differences in the social 
experiences of young people with a learning disability. Further research could therefore 
focus on the unique experiences of this population, particularly given the potential for 
stigma to be associated with both epilepsy and the learning disability. Given the limited 
amount of research into stigma in the lives of adolescents with epilepsy, further research is 
necessary in order to help develop a clearer understanding of how stigma is experienced 
within this population.
Study Limitations
Due to the small sample size the results are not generalizable, although it should be 
acknowledged that this is not an aim of qualitative research. It is relevant that the accounts 
within this study are based on a sample of young people who volunteered to talk about 
their epilepsy with someone they did not know. It may be hypothesised that young people 
with a strong sense of stigma would not volunteer to take part in a study of this type. 
Consequently, important insights into adolescents’ experiences of stigma may not have 
emerged from within the present study. We do not have information about the young 
people who did not opt-in, therefore it is not possible to make inferences about their 
reasons for not participating. Further research adopting longitudinal design may assist 
researchers in gaining a broader perspective of stigma in the lives of young people with 
epilepsy.
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Table 1: Participant Characteristics
Participant Characteristics
Gender (number) 
Male 5
Female 4
Age (year, month) 
Mean 15.7
Range 12.11-17.10
Seizure Type (number) 
Simple partial 1
Complex partial 7
Generalised Tonic Clonic 7
Absence 1
More than one seizure type 6
Age at diagnosis (year, month) 
Mean 7.10
Range 1.0-15.10
Seizure Frequency (number) 
Daily 1
Weekly 3
Monthly 1
Several times a year 2
Once a year 0
Less than one a year 2
Medication (number) 
Sodium Valporate 1
Carbamazepine 5
Levetiracetam 2
Lamotrigine 1
Zonisamide 1
Clobazam 1
Oxcarbamazepine 2
Phenytoin 1
None 0
Polypharmacy 4
Vagus Nerve Stimulation 2
Education Status
Mainstream school 6
Special needs school 1
College* 2
* One of the participants attending college, previously attended a special needs school
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Figure 1: Analysis Flowchart
First transcript
Emerging themes and titles were documented 
in the right-hand margin.
Anything interesting or significant was 
annotated in the left-hand margin.
Transcript read repeatedly to become familiar 
with the account.
Once all transcripts were analysed, 
a final table of themes was 
constructed.
Process repeated for each transcript, 
with themes from previous 
transcripts used to orient the 
analysis of subsequent transcripts.
Emergent themes were listed in a table, 
alongside supporting quotations from the text. 
Themes which formed clusters were given a 
name and represented superordinate themes.
If a superordinate theme emerged late in the analysis, earlier transcripts were reviewed 
in the light of the new superordinate theme.
During all stages of analysis the researcher constantly checked their own interpretations 
against what the person actually said.
Themes were not only selected by their prevalence within the data, but also on the 
power of their expression and the extent to which they illuminate other themes.
Themes were dropped if they did not fit well with the emerging structure, nor were rich 
in evidence within the transcript.
Key Processes of Analysis
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Chapter 5: Single N Proposal
Single N Proposal submitted in partial fulfilment of the requirements for the degree of
Doctorate in Clinical Psychology
The contribution of a solution-focused approach to 
deliberate self-harm in adolescence: 
A single case design.
Katherine Bruce
Section of Psychological Medicine,
Division of Community Based Sciences, 
Academic Centre,
University of Glasgow, Gartnaval Royal Hospital, 
1055 Great Western Road,
Glasgow G1 OXH 
Tel: 0141 211 3927 
Fax: 014 357 4899
ABSTRACT
Background: Deliberate self-harm is a significant problem within the adolescent 
population, however there remains a poor evidence-base for effective interventions. 
Solution focused therapy may provide a valuable contribution, through its focus on 
strengths, coping-skills and hope for the future.
Aims: The proposed study aims to investigate the effectiveness of solution focused 
brief therapy as part of an intervention for reducing the frequency of deliberate self- 
harm in an adolescent. The effects of intervention on associated psychological factors 
shall also be evaluated.
Method: A single-case ABCD design shall be utilised, incorporating phases of 
baseline assessment, traditional intervention, solution-focused intervention and 
follow-up. Measurements of outcome will include frequency of self-harm, symptoms 
of depression, self-esteem, problem solving, self-efficacy and impulsivity.
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Appendix 1.1: Data Collection Form
Data Collection Form
ID Randomly allocated to each referral
Age at referral In years only
Gender Male/Female
Referral source GP, Psychiatry etc.
Presenting problem as assessed by the 1. Cognitive impairment
referrer 2. Axis II  Disorder (e.g. LDS’ ADHD etc.)
3. Alcohol/substance related cognitive deficit?
Neuropsychologist’s formulation Descriptive (post-hoc categorization used)
Postcode O f patients address
Catchment area of Lochgilphead service Tarbert, Oban, M id Argyll\ Campbeltown, 
Cowal Peninsula, Bute
Attendance at first appointment A ttended/Cancelled/DNA
Date of referral dd/mm/yy
Date of first appointment given dd/mm/yy
Date of first appointment attended dd/mm/yy
Date of discharge from assessment clinic dd/mm/yy
Tested Yes/no
If not tested why? Descriptive
Test 1 Name (In the case o f only individual subtests 
being given, they shall be addressed by the 
whole test name)
Test 2 Name
Test 3 Name
Test 4 Name
Test 5 Name
Test 6 Name
Number of sessions seen by 
Neuropsychologist
Number
Number of sessions seen by Trainee 
Clinical Psychologist
Number
Number of sessions seen by Assistant 
Psychologist
Number
Other services involved with case List (post-hoc categorization used)
Neuropsychologist recommendations 
following assessment
List (post-hoc categorization used)
Outcome of case 1. Returned o referrer unseen
2. Returned to referrer seen
3. Returned to another service
4. Returned to another psychologist
5. Case currently still open to NAS
Followed-up within NAS Yes/no
Nature of follow-up Descriptive
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Appendix 1.2: Power Point Presentation
Analysis o f Referrals to a New Neuropsychology 
Assessment Service within Argyll and Bute 
Adult Clinical Psychology Service
Small Scale Service Related Project submitted in partial fnlfilhn en l of the 
requirements for the degree o f Doctorate in Clinical Psychology
Katherine Bruce
Argyll and Bute Neuropsychology Assessment 
Service (NAS)
• Peck report (2001)
• Service established (March 2004)
• Covering Argyll and Bute population
• In-patient and out-patient
• Based at Argyll and Bute Hospital
• Referrals screened by Head of Argyll and 
Bute Clinical Psychology Services
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NAS: Staffing
• Neuropsychologist -  1 day a month
• Assistant Psychologist -  Supervised in 
administering of tests and follow-up work
• Opportunity for Trainee Clinical 
Psychologists to work within NAC
The rural 
nature of 
Argyll an Bute
Formal Links 
with Other 
Services/ 
Integrated 
Care Pathway
Guidelines and 
recommendations 
for specific 
patient 
populations
Considerations for 
Future 
Development
Aims and Objectives of the Study
1) Who used the service and what types of referrals 
were received?
2) What is the nature of the assessment service 
provided to the referred population?
3) What were the outcomes of cases seen within 
the service?
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Method
• Data collected from case-notes
• Referrals accepted from 1st May 2004 to 
31st January 2005
• Data collection form used
• Database created in Access
• Data analysed within Excel
• Patient confidentiality protected
Results
Accepted Referrals
15 referrals accepted for assessment in the first 9 months
N umber of Accepted Retcmls to NAS cacti Month
54
•fear  3- 
MfcrralB 2-I
I X
Jur M  TM Aug 
um w w tM
Average waiting time = 30 days
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Demographic Characteristics
9 males and 6 females assessed
Ag# Rang* of Pa ten ts  Accepted for A ssessment
..II
Demographic Characteristics
Average distance Estimated mean length
travelled one-way from a of time taken to travel
patient’s home address to one-way by car to a
the clinic singe appointment
33.5 miles 87.6 minutes
Reforals made for patients living within all 6 
catchment areas
Referral Source and Reason
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Attendance
All 15 referrals attended the service 
for the duration of their assessment
Formal Neuropsychological Testing
Average of 4 
tests 
administered 
for each of 
the 13 
patients who 
received 
formal 
testing.
Appointments
Mean number of appointments attended were 
2.8 appointments per assessment episode.
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Assessment Episode Length
Mean length of 
completed assessment 
episodes
97 days
Main reason is 
due to a delay in 
writing of 
assessment 
reports
<dSometimesawaiting
f u r th e r
information
Sometimes no 
obvious reason 
for delay
Is the balance 
of time 
between 
clinical work 
and
administrative 
work 
functioning at 
the correct 
level?
Problem Type Following Assessment
Other Services Involved
53% of cases did not appear to 
have other services 
simultaneously involved in the 
assessment/care of the case.
Cases with other services involved 
included: OT, Neurology, Psychiatry 
and the Physically Disabled 
Rehabilitation Unit.
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Outcome of Cases
■10 cases returned to the 
referrer with 
recommendations
•5 cases remain open
■3 of the open cases are 
awaiting follow-up from the 
Psychol ogy Assistant
•2 of the open cases are 
awaiting re-assessment 
within the NAS to monitor 
change
Conclusions/Future Implications
• Implications for other services
• Positive results are 0% rate of non-attenders 
within the context of long journey times
• Consideration to future planning of appointments 
to suit patient’s journeys?
• Future service developments
• Impact of temporary loss of Psychology Assistant 
input
• Impact of dissolution of NHS Argyll and Clyde
Discussion 
and Further Action
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Appendix 2.1: Elsevier Guide for Authors (for submission to  Seizure)
Guide for Authors 
Submission checklist
It is hoped that this list will be useful during the final checking of an article prior to sending it to the journal's 
editor for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
• One author designated as corresponding author
• E-mail address
• Full postal address
• Telephone and fax numbers
• All necessary files have been uploaded
• Keywords
• All figure captions
• All tables (including title, description, footnotes)
• Further considerations
• Manuscript has been "spell checked"
• References are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Web)
• Colour figures are clearly marked as being intended for colour reproduction or to be reproduced in \ 
black-and-white
For any further information please contact the Author Support Department at 
authorsupport@elsevier.com
Submission of articles 
General
Submission of an article implies that the work described has not been published previously (except in the form of 
an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication 
elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities 
where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in 
English or in any other language, without the written consent of the Publisher.
Upon acceptance of an article, authors will be asked to transfer copyright. This transfer will ensure the widest 
possible dissemination of information. A letter will be sent to the corresponding author confirming receipt of the 
manuscript. A form facilitating transfer of copyright will be provided.
If excerpts from other copyrighted works are included, the authors) must obtain written permission from the 
copyright owners and credit the source(s) in the article. Elsevier has pre-printed forms for use by authors in these 
cases: contact Elsevier Global Rights Department, P.O. Box 800, Oxford, 0X5 1DX, UK; phone: (+44) 1865 
843830, fax: (+44) 1865 853333, peTmissions@elsevier.com
Should authors be requested by the editor to revise the text, the revised version should be submitted within two 
months. After this period, the article will be regarded as a new submission.
On-line submission to the journal prior to acceptance
Submission to this journal proceeds totally on-line. Use the following guidelines to prepare your article. Via the 
"Author Gateway" page of this journal (http://authors.elsevier.com/ioumal/seizuret you will be guided stepwise 
through the creation and uploading of the various files. Once the uploading is done, our system automatically 
generates an electronic (PDF) proof, which is then used for reviewing. It is crucial that all graphical and tabular 
elements be placed within the text, so that the PDF is suitable for reviewing. All correspondence, including 
notification of the Editor's decision and requests for revisions, will be by e-mail. In general, no separate proof is 
sent to you: the PDF is your proof. A proof will be provided only when the final layout of the article has to differ 
significantly from that in the initial PDF.
The above represents a very brief outline of this form of submission. It can be advantageous to print this 'Guide 
for Authors' section from the site for reference in the subsequent stages of article preparation.
Electronic format requirements for accepted articles 
General points
We accept most word-processing formats, but Word, WordPerfect or LaTeX is preferred. Always keep a backup 
copy of the electronic file for reference and safety. Save your files using the default extension of the program 
used.
Word processed documents
It is important that the file be saved in the native format of the word processor used. The text should be in single­
column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and 
replaced on processing the article. In particular, do not use the word-processor's options to justify text or to 
hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. Do not embed 'graphically
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designed* equations or tables, but prepare these using the word-processor's facility. When preparing tables, if  you 
are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, 
use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of 
conventional manuscripts (see also the Author Gateway's Quickguide:
http://authors.elsevier.com/artwork/seizureY Do not import the figures into the text file but, instead, indicate their 
approximate locations directly in the electronic text and on the manuscript See also the section on Preparation of 
electronic illustrations.
To avoid unnecessary errors you are strongly advised to use the 'spellchecker* function o f your word processor.
Preparation of text 
Presentation of manuscript 
General
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Italics 
are to be used for expressions of Latin origin, for example, in vivo, et al., per se. Use decimal points (not 
commas); use a space for thousands (10 000 and above).
Set out the entire manuscript using double spacing and wide (3 cm) margins. (Avoid full justification, i.e., do not 
use a constant right-hand margin.) Ensure that each new paragraph is clearly indicated. Present tables and figure 
legends on separate pages at the end of the manuscript If possible, consult a recent issue of the journal to become 
familiar with layout and conventions. Number all pages consecutively.
Provide the following data on the title page (in the order given):
Title
Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae 
where possible.
Author names and affiliations
Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' 
affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case 
superscript letter immediately after the author's name and in front of the appropriate address. Provide the full 
postal address of each affiliation, including the country name, and, if available, the e-mail address of each author. 
Corresponding author
Clearly indicate who is willing to handle correspondence at all stages of refereeing and publication, also post­
publication. Ensure that telephone and fax numbers (with country and area code) are provided in addition 
to the e-mail address and the complete postal address.
Present/permanent address
If an author has moved since the work described in the article was done, or was visiting at the time, a Present 
address' (or Permanent address') may be indicated as a footnote to that author's name. The address at which the 
author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are 
used for such footnotes.
Abstract
A concise and factual abstract is required (maximum length 250 words). The abstract should state briefly the 
purpose of the research, the principal results and major conclusions. An abstract is often presented separate from 
the article, so it must be able to stand alone.
References should therefore be avoided, but if essential, they must be cited in full, without reference to the
reference list
Keywords
Immediately after the abstract, provide a maximum of six keywords, avoiding general and plural terms and 
multiple concepts (avoid, for example, 'and', 'of). Be sparing with abbreviations: only abbreviations firmly 
established in the field may be eligible. These keywords will be used for indexing purposes.
Abbreviations
Define abbreviations that are not standard in this field at their first occurrence in the article: in the abstract but 
also in the main text after it Ensure consistency of abbreviations throughout the article.
Acknowledgements
Collate acknowledgements in a separate section at the end of the article and do not, therefore, include them on the 
title page, as a footnote to the title or otherwise.
Arrangement of the article 
Subdivision of the article
Divide your article into clearly defined sections. Each subsection is given a brief heading. Each heading should 
appear on its own separate line. Subsections should be used as much as possible when cross-referencing text: refer 
to the subsection by heading as opposed to simply the text'
Introduction
State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a 
summary of the results.
Experimental/Materials and methods
Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a 
reference: only relevant modifications should be described 
Theory and/or calculation
A Theory section should extend, not repeat the background to the article already dealt with in the Introduction 
and lay the foundation for further work. In contrast, a Calculation section represents a practical development from 
a theoretical basis.
Results
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In this section the findings should be described clearly, concisely, and in logical order without extended 
discussions of their significance. Only in case of short communications, the results and discussion sections may 
be combined. Results should usually be presented in graphic or tabular form, rather than discursively. There 
should be no duplication in ted, tables and figures. Experimental conclusions should normally be based on 
adequate numbers of observations with statistical analysis of variance and the significance of differences. The 
number of individual values represented by a mean should be indicated 
Discussion
This section should present conclusions to be drawn from the results accompanied by an assessment of their 
significance in relation to previous work. Speculative discussion is not discouraged, but the speculation should be 
based on the data presented and identified as such. In general, the discussion should be as concise as possible. 
Conclusions
The main conclusions of the study may be presented in a short Conclusions section, which may stand alone or 
form a subsection of a Discussion or Results and Discussion section.
Acknowledgements
Place acknowledgements, including information on grants received, before the references, in a separate section, 
and not as a footnote on the title page.
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See separate section, below.
Figure legends, tables, figures, schemes
Present these, in this order, at the end of die article. They are described in more detail below. High-resolution 
graphics files must always be provided separate from the main text file (see Preparation of illustrations).
Text graphics
Present incidental graphics not suitable for mention as figures, plates or schemes at the end of the article and 
number them 'Graphic 1', etc. Their precise position in the text can then be defined similarly (both on the 
manuscript and in the file). See further under the section, Preparation of illustrations. Ensure that high-resolution 
graphics files are provided, even if the graphic appears as part of your normal word processed text file.
Specific remarks 
Mathematical formulae
Present simple formulae in the line of normal text where possible. In principle, variables are to be presented in 
italics. Use the solidus (/) instead of a horizontal line, e g. X/Y rather than
X
Y
Powers of e are often more conveniently denoted by exp.
Number consecutively any equations that have to be displayed separate from the text (if referred to explicitly in 
the text).
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Footnotes should be used sparingly. Number them consecutively throughout the article, using superscript Arabic 
numbers. Many word processors build footnotes into the text, and this feature may be used. Should this not be the 
case, indicate die position of footnotes in the text and present the footnotes themselves on a separate sheet at the 
end of the article. Do not include footnotes in the Reference list.
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501).
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For each and every accession number cited in an article, authors should type the accession number in bold, 
underlined text Letters in the accession number should always be capitalised. (See Example below). This 
combination of letters and format will enable Elsevier's typesetters to recognise the relevant texts as accession 
numbers and add the required link to GenBank's sequences.
Example: "GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a 
chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession 
no. AA361117)
Authors are encouraged to check accession numbers used very carefully. An error in a letter or number can 
result in a dead link. In the final version of the printed article, the accession number text will not appear bold or 
underlined. In the final version of the electronic copy, the accession number text will be linked to the appropriate 
source in the NCBI databases enabling readers to go directly to that source from the article.
Preparation o f supplementary data. Elsevier now accepts electronic supplementary material to support and
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enhance your scientific research. Supplementary files offer the author additional possibilities to publish 
supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips 
and more. Supplementary files supplied will be published online alongside the electronic version of your article in 
Elsevier web products, including ScienceDirect: htto://www. sciencedirect.com. In order to ensure that your 
submitted material is directly usable, please ensure that data is provided in one of our recommended file formats. 
Authors should submit the material in electronic format together with the article and supply a concise and 
descriptive caption for each file. For more detailed instructions please visit our Author Gateway at 
http://authors.elsevier.com/artwork/seizure. This journal offers electronic submission services and supplementary 
data files can be uploaded via the Author Gateway page of this journal via r - - *  
http://authors.elsevier. com/i oumal/seizure.
Policy and ethics
The work described in your article must have been carried out in accordance with 
The Code of Ethics of the World Medical Association(Declaration of Helsinki) for experiments involving 
humans; http://www.wma.net/e/policv/17-a e.html and EC Directive 86/609/EEC for animal experiments; 
http://europa.eu.int/scadplus/leg/en/s23000.htm. This must be stated at an appropriate point in the article. 
Protection of patients' rights to privacy
Patients have rights to privacy that should not be infiinged without informed consent Identifying information 
should not be published in written descriptions, photographs, or pedigrees unless the information is essential for 
scientific purposes and the patient (or parent or guardian) gives written consent for publication. Informed consent 
for this purpose requires that the patient should be shown the manuscript to be published.
Identifying details should be omitted if they are not essential, but patient data should never be altered or falsified 
in an attempt to attain anonymity. Complete anonymity is difficult to achieve, and informed consent should be 
obtained if there is any doubt, for example, masking of the eye region in photographs of patients is inadequate 
protection of anonymity. When informed consent has been obtained it should be indicated in the published article. 
Statement of conflict of interest
Authors must state possible conflicts of interest when submitting a manuscript State any potential conflict of 
interest between any possible commercial or governmental sponsorship and the manuscript in question. Conflict 
of interest might arise if the author has been paid to write the piece, or if s/he is giving their name to a manuscript 
'ghost written' by somebody else, if the research has been sponsored by a government or a company, if the 
author's department or research programme is dependent on sponsorship or donation from a relevant company. If 
authors do not make a declaration we may ask them to do so. Where research, for example from a focus group or 
a research team, is written up by a third party, we expect all named authors to very carefully read the manuscript 
before putting their names to it to ensure that it accurately reflects their views, and to ask Is there a potential 
conflict of interest here?
References
Responsibility for the accuracy of bibliographic citations lies entirely with the authors.
Citations in the text
Please ensure that every reference cited in die text is also present in the reference list (and vice versa). Any 
references cited in the abstract must be given in full. Unpublished results and personal communications should not 
be in the reference list, but may be mentioned in the text. Citation of a reference as 'in press' implies that the item 
has been accepted for publication.
Citing and listing of web references
As a minimum, the full URL should be given. Any further information, if known (author names, dates, reference 
to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the 
reference list) under a different heading if desired, or can be included in the reference list.
Text
Indicate references by numbei(s) in square brackets in line with the text. The actual authors can be referred to, but 
the reference numbers) must always be given.
Example:
" as demonstrated [3,6]. Bamaby and Jones [8] obtained a different result...."
List. Number the references (numbers in square brackets) in the list in the order in which they appear in the text. 
Examples:
Reference to a journal publication:
[1] Slater, E. and Beard, A.W. The Schizophrenia-like psychoses of epilepsy. British Journal of Psychiatry 
1963;109:95-150.
Reference to a book:
[2] W. Strunk Jr., E.B. White, The Elements of Style, third ed., Macmillan, New York, 1979.
Reference to a chapter in an edited book:
[3] Betts, T.A. A follow up study of a cohort of patients with epilepsy admitted to psychiatric care in an English 
city. In: Proceedings of the Hans Berger Centenary Symposium (Eds P. Harris and C.Maudsley). Edinburgh, 
Churchill Livingstone, 1974: pp.326-338.
Note that journal names are not to be abbreviated and that "et al." is used if there are seven or more authors. 
Preparation of illustrations 
Preparation of electronic illustrations
Submitting your artwork in an electronic format helps us to produce your work to the best possible standards, 
ensuring accuracy, clarity and a high level of detail.
General points
• Always supply high-quality printouts of your artwork, in case conversion of the electronic artwork is 
problematic.
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• Make sure you use uniform lettering and sizing of your original artwork.
• Save text in illustrations as "graphics" or enclose the font
• Only use the following fonts in your illustrations: Arial, Courier, Helvetica, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files, and supply a separate listing of the files and the software 
used.
• Provide all illustrations as separate files.
• Provide captions to illustrations separately.
• Produce images near to the desired size of the printed version.
This journal offers electronic submission services and graphic files can be uploaded via the Author Gateway page 
of this journal via http://authors.elsevier.com. A detailed guide on electronic artwork is available on our website: 
http://authors.elsevier.com/artwork
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless of the application used, when your electronic artwork is finalised, please "save as" or convert the 
images to one of the following formats (Note the resolution requirements for line drawings, halftones, and 
line/halftone combinations given below.):
EPS: Vector drawings. Embed the font or save the text as "graphics".
TIFF: Colour or greyscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (colour or greyscale): a minimum of 500 dpi is required.
DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications please 
supply "as is".Please do not:
• Supply embedded graphics in your word processor (spreadsheet, presentation) document;
• Supply files that are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low,
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content 
Captions
Ensure that each illustration has a caption. Supply captions on a separate sheet, not attached to the figure. A 
caption should comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the 
illustrations themselves to a minimum but explain all symbols and abbreviations used.
Colour illustrations
Submit colour illustrations as original photographs, high-quality computer prints or transparencies, close to the 
size expected in publication, or as 35 mm slides. Polaroid colour prints are not suitable. If, together with your 
accepted article, you submit usable colour figures then Elsevier will ensure, at no additional charge, that these 
figures will appear in colour on the web (e.g., ScienceDirect and other sites) regardless of whether or not these 
illustrations are reproduced in colour in the printed version. For colour reproduction in print, you will receive 
information regarding the costs from Elsevier after receipt of your accepted article. For further information on the 
preparation of electronic artwork, please see http://authors.elsevier.com/artwork
Please note: Because of technical complications which can arise by converting colour figures to 'grey scale' (for 
the printed version should you not opt for colour in print) please submit in addition usable black and white prints 
corresponding to all the colour illustrations.
Proofs
When your manuscript is received by the Publisher it is considered to be in its final form. Proofs are not to be 
regarded as 'drafts'.
One set of page proofs in PDF format will be sent by e-mail to the corresponding author, to be checked for 
typesetting/editing. No changes in, or additions to, the accepted (and subsequently edited) manuscript will be 
allowed at this stage. Proofreading is solely your responsibility. A form with queries from the copyeditor may 
accompany your proofs. Please answer all queries and make any corrections or additions required.
The Publisher reserves the right to proceed with publication if corrections are not communicated.
Return corrections within 2 days of receipt of the proofs. Should there be no corrections, please confirm this. 
Elsevier will do everything possible to get your article corrected and published as quickly and accurately as 
possible. In order to do this we need your help. When you receive the (PDF) proof of your article for correction, it 
is important to ensure that all of your corrections are sent back to us in one communication. Subsequent 
corrections will not be possible, so please ensure your first sending is complete. Note that this does not mean you 
have any less time to make your corrections, just that only one set of corrections will be accepted.
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Appendix 2.2: Quality Criteria Rating System
Title of Study: Initials of Rater:
1) Design
What is the design of the study?
a) Longitudinal n
b) Cross-sectional □
21 Generalizabilitv of the findines
How representative were participants of the defined population?
a) The study utilised a good sampling technique (e.g. geographical 
cohort), to recruit participants representative of the defined 
population.
b) Criteria a) was not fully met, but the authors justified an adequate 
sampling method, to attempt to ensure a representative sample.
c) The study did not utilise an adequate sampling technique (e.g. 
convenience sample), which may have comprised the 
generalizability of the findings.
3) Confounding Variables
How well were confounding variables accounted for?
a) The study identified and accounted for key possible confounding 
variables in the analysis. These included variables within each of 
the following four categories: 1) demographic variables 2) neuro- 
epilepsy variables 3) psychosocial variables 4) medication 
variables (examples highlighted in table 1).
b) Criterion a) was not fully met, but analysis took into account 
some possible confounding variables. These included variables 
within at least two of the following categories: 1) demographic 
variables 2) neuro-epilepsy variables 3) psychosocial variables 4) 
medication variables (examples highlighted in table 1).
c) Key possible confounding variables were not adequately 
considered in the analysis. This includes studies which took into 
account variables from only one or none of the following 
categories: 1) demographic variables 2) neuro-epilepsy variables
3) psychosocial variables 4) medication variables (examples 
highlighted in table 1).
Good □  
Adequate □
Poor □
Good □  
Adequate □
Poor □
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Table 1: Examples of Key Possible Confounding Variables
Demograph 
ic Variables
Neuroepilepsy
Variables
Psychosocial
Variables
Medication
Variables
□  Age
□  Sex
□  Race
□  Age at onset
□  Seizure control
□  Duration of disorder
□  Seizure type
□  Multiple seizure types
□  Etiology of epilepsy
□  Type of aura
□  Neuropsychological status
□  Fear of seizures
□  Perceived discrimination
□  Adjustment to epilepsy
□  Locus of control
□  Life event changes
□  Social support
□  Socio-economic status
□  Childhood home 
environment
□  Number of 
medications
□  Serum level
□  Medication type
□  Folic acid level
4) Reliability/Validity of Assessment Measures
How reliable/valid are the assessment measures?
a) The study utilised reliable and valid measures for the assessment 
of perceived stigma and the assessment of psychopathology (or 
symptoms/indicative of psychopathology). Good □
b) Criteria a) was not fully met, but adequate measures of perceived 
stigma and psychopathology were justified by the authors of the
study. Adequate □
c) The study did not utilise adequate measures for the assessment of
perceived stigma and the assessment of psychopathology. Poor □
Quality Rating
1 = Longitudinal design
2 = Cross-sectional design
i) = Two or more ratings of Good
ii) = Two or more ratings of Adequate or one of each (Poor, Adequate, Good).
iii) = Two or more ratings of Poor
Overall Quality Rating:
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Appendix 3.1.1: Participant Invite Letters
(Letter sent when only participant consent required)
NHS\  _
& '
Greater Glasgow  
and Clyde
[On Headed Paper o f Unit]
Dear (insert name)
I would like to invite you to take part in a study being carried out by Katherine Bruce, a 
Trainee Clinical Psychologist at the University of Glasgow. The aim of her study is to 
investigate young people’s experiences of living with epilepsy, and how they feel this 
impacts on their life.
To help you decide whether you want to take part, Katherine has written an information 
sheet which tells you all about the study. The information sheet also has contact numbers if 
you wish to discuss the study in more detail. If you do not wish to take part, you do not 
have to do anything else. Deciding not to take part will not affect the standard of care you 
receive in any way.
If you decide you do want to take part in the study, please complete the opt-in form and 
return it in the FREEPOST envelope provided.
Best wishes
Signed by clinician at appropriate unit.
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(Letter sent when parental consent required)
N H S
Greater Glasgow  
and Clyde
[On headed paper o f Unit]
Dear (insert name)
I would like to invite your child to take part in a study being carried out by Katherine 
Bruce, a Trainee Clinical Psychologist at the University of Glasgow. The aim of her study 
is to investigate young people’s experiences of living with epilepsy, and how they feel this 
impacts on their life.
To help you and your child decide whether to take part, Katherine has written information 
sheets which tells you all about the study. The information sheets also have contact 
numbers if you wish to discuss the study in more detail. If you do not wish your child to 
take part, you do not have to do anything else. Deciding not to take part will not affect the 
standard of care your child receives in any way.
If your child decides they do want to take part in the study, and you are in agreement with 
this, please complete the opt-in form and return it in the FREEPOST envelope provided.
Best wishes
Signed by clinician at appropriate unit.
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Appendix 3.1.2: Information Sheets (Young Person and Parent)
Study title: A qualitative investigation into the social experiences of young 
people with epilepsy; perceived impact and sense of self
Thank you for reading this information sheet. My name is Katherine Bruce, and I 
am a psychologist at the University of Glasgow. I am doing a study which is 
looking at how epilepsy affects young people in their daily lives, by speaking with 
young people themselves.
You are being invited to take part in this research study. Before you decide 
whether to take part, it is important for you to understand why the research is 
being done and what you will be asked to do. Please take time to read the 
following information carefully and discuss it with others if you wish. You can 
contact myself if there is anything that is not clear or if you have any questions. 
Take time to decide whether or not you wish to take part.
What is the study for?
This study is looking at young people’s experiences of living with epilepsy, and 
how they feel this impacts on their life. W e want to know about young people’s 
experiences at school and in their social life, so people have a better 
understanding of what it is like to live with epilepsy. Sometimes studies ask 
parents and teacher what their views are, but we are interested in speaking to 
young people themselves, as they are the experts. The results of this study should 
help medical staff provide better care, and would be useful in informing future 
public information campaigns.
Why have I been chosen?
All young people aged between 12 and 18 years old who have epilepsy and attend 
either the Fraser of Allander Unit or the Epilepsy Unit, could be invited to take part 
in the study. This is to get a really good understanding of what it’s like to have 
epilepsy as a young person, by talking to young people themselves. You are the 
experts about what it is like to live with epilepsy, therefore we are interested in 
listening to your experiences.
Do I have to take part?
It is up to you if you decide whether or not to take part. If you do decide to take 
part you will be asked to sign a consent form. If you decide to take part you are still 
free to withdraw at any time and without giving a reason. A decision to withdraw at 
any time, or a decision not to take part, will not affect the standard of care you 
receive.
What will happen to me if I take part?
ITyou decide to take.part in the study, then I will arrange 3 time for us to meet at 
the {Fraser of Allander Neurosciences UnitAhe Epilepsy Unit}. W e will use a room 
there to sit and talk, which should take approximately one hour. There will be no 
physical examination, just a chance for you to talk to me about some your
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experiences of living with epilepsy. Our conversation will be audio-taped, so that I 
can remember what was said, but only my research supervisor and myself will be 
allowed to listen to these tapes. A contribution towards your travel expenses will 
be provided for any visits to the clinic required for the purpose of the research.
What are the possible disadvantages of taking part?
There are no real risks of taking part. You will not be asked to do anything other 
than talk about your experiences of living with epilepsy. If during our meeting there 
are any things you are particularly worried about, let me know and I will arrange 
and appointment for you to talk to a clinician at the Fraser of Allander Unit.
What are the possible benefits of taking part?
The information you and others give us will help people better understand what it 
is like for young people living with epilepsy. The results of this study should help 
medical staff provide better care, and would be useful in informing future public 
information campaigns.
Will my taking part in this study be kept confidential (private)?
All information which is collected about you will be kept strictly confidential. Any 
information about you will have you name and address removed so that you 
cannot be identified. Only my supervisor and myself will be able to listen to the 
audio-tape recordings of the interview. The tapes and any other information will be 
stored in locked cabinets and will be destroyed after 10 years of the study being 
completed. The only reason I would have to break confidentiality, is if I was 
worried about your or someone else’s safety. If this were to happen, and with your 
knowledge beforehand, I would have to tell the appropriate people.
What will happen to the results of the research study?
This research is being carried out as part of the Doctorate in Clinical Psychology. It 
is intended that the results be published in a journal specialising in epilepsy 
research. Quotations from the interviews may be used within the write-up of the 
study, but there will be no way of identifying you, as all names and personal 
information will be removed. You will be able to get a copy of the article from me 
once it is published.
Contact for Further Information
If you have any questions you would like to ask, you can contact my supervisor or
me:
Katherine Bruce,
Trainee Clinical Psychologist, 
Department of Psychological Medicine 
Academ ic Centre 
Gartnavel Royal Hospital 
G lasgow
Email: k.bruce.1@ research.gla.ac.uk  
Telephone num ber 07902293700
Dr. Andrew Jahoda
Clinical Psychologist
Department of Psychological Medicine
Academ ic Centre
Gartnavel Royal Hospital
G lasgow
E m ail: aj26r@clinmed.gla.ac.uk 
Telephone number: 0141 211 0693
t i i a n i s 'm  h t  hi lnii : i  iii-I?
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Study title: A qualitative investigation into the social experiences of young 
people with epilepsy; perceived impact and sense of self
Thank you for reading this information sheet. My name is Katherine Bruce, and I 
am a psychologist at the University of Glasgow. I am doing a study which is 
looking at how epilepsy affects young people in their daily lives, by speaking with 
young people themselves.
Your child is being invited to take part in this research study. Before they decide 
whether to take part, it is important for them to understand why the research is 
being done and what they will be asked to do. Please take time to read the 
following information carefully and discuss it with your child. You can contact 
myself if there is anything that is not clear or if you have any questions.
What is the study for?
This study is looking at young people’s experiences of living with epilepsy, and 
how they feel this impacts on their life. W e want to know about young people’s 
experiences at school and in their social life, so people have a better 
understanding of what it is like to live with epilepsy. Sometimes studies ask 
parents and teacher what their views are, but we are interested in speaking to 
young people themselves. The results of this study should help medical staff 
provide better care, and would be useful in informing future public information 
campaigns.
Why has my child been chosen?
All young people aged between 12 and 18 years old who have epilepsy and attend 
either the Fraser of Allander Unit or the Epilepsy Unit, could be invited to take part 
in the study. This is to get a really good understanding of what it’s like to have 
epilepsy as a young person, by talking to young people themselves.
Does my child have to take part?
It is up to you and your child to decide whether or not they should take part. If you 
and your child do decide to take part you will both be asked to sign a consent 
form. If your child does decide to take part they are free to withdraw at any time 
and without giving a reason. A decision to withdraw at any time, or a decision not 
to take part, will not affect the standard of care they receive.
What will happen to my child if they take part?
If they decide to take part in the study, then your child will be invited to the {Fraser 
of Allander Neurosciences Unit/the Epilepsy Unit}} where we will use a room there 
to sit and talk. This should take approximately one hour. There will be no physical 
examination, just a chance for them to talk about some of their experiences of
living with epilepsy. Our conversation will be audio-taped, so that I can remember
what was said, but only my research supervisor and myself will be allowed to listen
to these tapes. A contribution towards your travel expenses will be provided for 
any visits to the clinic required for the purpose of the research.
What are the possible disadvantages of taking part?
There are no real risks of taking part. Your child will not be asked to do anything 
other than talk about their experiences of living with epilepsy. If during our meeting 
there are any things they are particularly worried about, I will arrange an 
appointment for them to talk to a clinician at the Fraser of Allander Unit.
What are the possible benefits of taking part?
The information your child gives us will help people better understand what it is 
like for young people living with epilepsy. The results of this study should help 
medical staff provide better care, and would be useful in informing future public 
information campaigns.
Will my child taking part in this study be kept confidential (private)?
All information which is collected about your child will be kept strictly confidential. 
Any information about them will have their name and address removed so that 
they cannot be identified. Only my supervisor and myself will be able to listen to 
the audio-tape recordings of the interview. The tapes and any other information 
will be stored in locked cabinets and will be destroyed after 10 years of the study 
being completed. The only reason I would have to break confidentiality, is if I was 
worried about your child’s or someone else’s safety. If this were to happen I would 
have to tell the appropriate people.
What will happen to the results of the research study?
This research is being carried out as part of the Doctorate in Clinical Psychology. It 
is intended that the results be published in a journal specialising in epilepsy 
research. Quotations from the interviews may be used within the write-up of the 
study, but there will be no way of identifying your child, as all names and personal 
information will be removed. You will be able to get a copy of the article from me 
once it is published.
Contact for Further Information
If you have any questions you would like to ask, you can contact my supervisor or
me:
Katherine Bruce,
Trainee Clinical Psychologist, 
Department of Psychological Medicine 
Academ ic Centre 
Gartnavel Royal Hospital 
G lasgow
Email: k.bruce.1@ research.gla.ac.uk  
Telephone num ber 07902293700
Dr. Andrew Jahoda
Clinical Psychologist
Department of Psychological Medicine
Academ ic Centre
Gartnavel Royal Hospital
G lasgow
E m ail: aj26r@ clinmed.gla.ac.uk 
Telephone num ber 0141 211 0693
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Appendix 3.1.3: Opt-in Forms
(Opt-in form when only participant consent required)
NHS
Greater Glasgow  
and Clyde
UNIVERSITY
GLASGOW
Centre No:
Study No:
Participant Identification No:
OPT-IN FORM
Title of Study
A qualitative investigation into the social experiences of young people with epilepsy; 
perceived impact and sense of self
If you would like to take part in this study, please complete the following and return it in 
the stamped addressed envelope:
Name:__________________________________________________________________
Address: ______
Contact telephone number:
Once I have received this form I will contact you by telephone to arrange a time for us to 
meet.
Yours Sincerely
Katherine Bruce
Trainee Clinical Psychologist
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(Opt-in form  when parental consent required)
NHS
Greater Glasgow 
and Clyde UNIVERSITY
of
GLASGOW
Centre No:
Study No:
Participant Identification No:
OPT-IN FORM
Title of Study
A qualitative investigation into the social experiences of young people with epilepsy; 
perceived impact and sense of self
If you are happy for your child to take part in this study, and your child also agrees, please 
complete the following and return it in the stamped addressed envelope:
Name of parent/guardian_________________________________________________
Name of child:__________________________________________________________
Address: ____
Contact telephone number:
Once I have received this form I will contact you by telephone to arrange a time for the 
interview.
Yours Sincerely
Katherine Bruce
Trainee Clinical Psychologist
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Appendix 3.2: Consent Forms
(Only participant consent required)
CONSENT FORM
Title of Study
A qualitative investigation into the social experiences of young people with epilepsy; 
perceived impact and sense of self
Researcher
Katherine Bruce, Trainee Clinical Psychologist
Address for Correspondence: Department of Psychological Medicine
Academic Centre 
Gartnavel Royal Hospital 
1055 Great Western Road 
Glasgow 
G12 0XH
Please tick as appropriate
I have read and understood the information sheet | |
I have been given the opportunity to ask questions | |
I understand that I am free to withdraw from the study at any time without 
giving any reason and without my medical care or legal rights being affected 
and that on withdrawal from the study all information about me will be | |
destroyed.
I understand that that I shall be audio-taped during the interview, and that the 
recording will be kept in a locked filing cabinet and only listened to by the 
researcher and their supervisor.
I agree to take part in the above study 
Name of Participant..................................
Date.......................................... Signature.
Name of Researcher.......................................
Date.......................................... Signature.........
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□
I understand that some quotations from the interview may be used in the 
write-up and future publication of this study, but that there will be no way of 
identifying me, as all names and personal information will be removed. | |
I give permission for the researcher to obtain the following information from 
my clinician: 1) the age I was diagnosed with epilepsy 2) the type of seizures 
I experience 3) the frequency of my seizures 4) details of any current | |
medication. □
(Parental consent required)
CONSENT FORM
Title Study
A qualitative investigation into the social experiences of young people with epilepsy; perceived 
impact and sense of self
Researcher
Katherine Bruce, Trainee Clinical Psychologist
Address for Correspondence: Department of Psychological Medicine
Academic Centre 
Gartnavel Royal Hospital 
1055 Great Western Road 
Glasgow 
G12 0XH
Please tick as appropriate
My child and myself have read and understood the information sheet 
My child and myself have been given the opportunity to ask questions
I agree to my child taking part in the above study
Name of Parent/Guardian........................................
Date......................................... Signature................. .
Name of Participant..................................................
Date......................................... Signature..................
Name of Researcher.................................................
Date.........................................Signature................. .
□
□
I understand that my child is free to withdraw from the study at any time 
without giving any reason and without their medical care or legal rights being 
affected and that on withdrawal from the study all information about them will 
be destroyed.
I understand that that my child shall be audio-taped during the interview, and 
that the recording will be kept in a locked filing cabinet and only listened to by 
the researcher and their supervisor.
I understand that some quotations from the interview may be used in the write­
up and future publication of this study, but that there will be no way of 
identifying my child, as all names and personal information will be removed. Q
□
□
I give permission for the researcher to obtain the following information from 
my child’s clinician: 1) the age they were diagnosed with epilepsy 2) the type 
of seizures they experience 3) the frequency of their seizures 4) details of | |
current medication, if any.
□
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Appendix 3.3: Ethical Approval
Primary Care Division
Divisional Headquarters 
Gartnavel Royal Hospital 
1055 Greal Western Road 
GLASGOW G 120XH  
Telephone 0141 211 3600 
v> wn.nhsgg.arg.uk
Greater
Miss Katherine L 3 ruee Date 31 October 2006
Trainee Clinical Psycho'ogis: Your Ref
Greater Glasgc.v 5” c C c= 2m .e 's t ,  c* Cm Ref
Glasgow
C e c 2 " t r ^ e ,~t m  = = . m e  m ' m  Y e n  m e  C ' e r :  " m  I ' - 1' 1 ' '  1 5 1 -
Aeacer-c Ce-re  -s= I ' m  I ' ' IE
Ga— s . e  P:.. a - z s m e  E-— = _ i  , = -  e s m  T c = — =. e
r  -  “  •
Dear Miss Bruce
Full title of study: A qualitative investigation  into the  social exp erien ces  of
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Greater Gissoow
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Dear Miss Bruce
Project Reference Number: PNQ6CP016
Project Title: A qualitative investigation into the social experiences of young people with
epilepsy: perceived impact and sense of self
Thank you for your application for (R&D) Management Approval Application for the above study. I am 
pleased to inform you that R&D management approval has been granted by NHS Greater Glasgow & Clyde 
Community and Mental Health Partnership subject to the following requirements:
• You should notify me of any changes to the original submission and send regular, brief, interim 
reports including recruitment numbers where applicable. You must also notify me of any changes to 
the original research staff and send CVs of any new researchers.
• Your research must be conducted in accordance with the National Research Governance standards, 
(see CSO website: www.show.scot.nhs.uk/cso)
Local Research Governance monitonng requirements are presently being developed. This may 
involve audit of your research at some time in the future.
• You must comply with any regulations regarding data handling (Data Protection Act).
• Brief details of your study will be entered on the National Research Register (NRR). You will be 
notified prior to the next submission date and asked to check the details being submitted.
• A final report, with an abstract which can be disseminated widely within the NHS. should be 
submitted when the project has been completed.
Do not hesitate to contact the R & D office if you need any assistance.
Thank you again for your co-operation.
Yours sincerely
Brian Rae 
Research Manager
D3707R7
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Appendix 3.4: Interview Guide
Consent
Before the interview commences I will have introduced myself and the consent forms will have been 
discussed and signed.
Introduction to interview
• So, before we start, I will explain a bit about what we will be doing.
• I am doing research at the University of Glasgow. I am interested in hearing the views of young people 
who have epilepsy, which is why I am meeting with you today.
• I’d like to hear about some of your experiences of living with epilepsy, as well as your thoughts and 
feelings about it  You are the expert in this, and I am here to learn from you. I am meeting with a number 
of young people and I aim to gather all the information and look at what issues come out.
• I have some points written down here, which are just to remind me of the information I am interested in 
hearing about. So it’s not about getting through a list of questions, and there are no right or wrong 
answers.
• I may take some notes as we go along, but I will also be taping the interview, so that I can give you my 
full attention without missing anything.
• Just to remind you, the things that we talk about are private and will not be discussed with anybody who 
is not involved in this research. Any details that are discussed will be anonymised, which means your 
personal details will have been removed so you can’t be recognised.
• The only reason I could not keep what you say as private is if I was worried about your safety or 
someone else’s safety. If this were to happen, I would have to tell the appropriate people, but I would let 
you know before I did this.
• So, this will take approximately one hour. If you would like a drink, or need the toilet, just let me know. 
Have you any questions?
Ice-breaker/Engagement
“So, it would be good to start by finding out a bit about you and your life. I have a poster her, which I 
thought would be helpful to fill in. So if we put your name and age in the middle, and fill in these other 
boxes.” {{Using informal chat to facilitate engagement, participant can choose whether they write on the 
poster themselves and can choose from a variety o f  brightly coloured pens}}
Family: So who lives at 
home, names, ages and jobs? 
Are there other members of 
your family who you see 
regularly?
School/Work: Primary and 
Secondary school name? What 
school? What year?
Good/bad? Favourite bits? 
What lessons are you missing 
today, what year are you in, 
how’s school? What are 
teachers like? Member of 
clubs? Saturday job? 
Hobbies/Interests: what do 
you like to do outside of 
school? Clubs, interests, 
hobbies?
Friends: who are your close 
friends? different groups of 
friends?
“Great, this is veiy helpful, because I feel I know a bit more about you now. I will also be helpful when I am 
asking you about what it is like living with epilepsy, because I am interested in hearing what it is like in all 
these different areas of your life.”
Family
V
Scha* 1/Work
1
J
Hobbies/Interests ' ---------- r Friends
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1) So can you start by telling me a bit about how you first found out you had 
epilepsy?
If had epilepsy all their life:
Can you remember the first person you ever chatted to about epilepsy?
What sort of seizures do you 
have? How frequently? When 
was the last one? What are they 
like?
What did other people think 
about y o u  having epilepsy?
• Friends/Family/School
• Supportive?
What was that time like for you?
• How make feel?
• How react?
• Do you feel different about 
having epilepsy now?
Looking at these main headings, did any of these things 
change when you found out you had epilepsy?
If so. can you tell me more about that...
• Friendships?
• Hobbies?
• School?
• Home life?
Potential Prompts:
Impact: How did that feel / How did that effect you / did that change the way you behave 
now / Has that incident stopped you from doing anything
Coping: How did you react / What did you say / What did you do / How did other people 
react / What did other people say / What did other people do / What advice would you 
give to someone else in that position
Potential Comments:
That must have been difficult / Tell me more about that / That’s interesting / How did that 
make you feel / How did you react / Can you tell me a bit more about what that was like / 
That sounds like a difficult experience / That sounds like fun.
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2) Can you tell me about what is was like growing up with epilepsy?
Did you avoid 
doing anything 
because of 
epilepsy?
Can you think of any 
times that people have 
treated you differently 
because of your 
epilepsy?
• Reasons why?
• Reactions?
• Coping?
• Other times?
• Teasing
• Privacy?
Has growing up with epilepsy 
effected...?
• Things at home
• School
• Friendships
• Hobbies/Interests
Can you tell me about who knew 
you had epilepsy when you were 
growing up?
• School? Freinds? Family?
• How did they find out?
• Who didn’t know & why?
• Reactions when told?
• How do they react now?
Did you worry 
about things 
when you were 
growing up?
Can you tell me about 
what sort of 
experiences vou have 
had growing up with 
epilepsy?
• Seizures
• Teasing
• Hospital visits?
Unauthorised 
disclosure. 
How do you 
decide to tell 
someone?
Potential Prompts:
Impact: How did that feel / How did that effect you / did that change the way you behave 
now / Has that incident stopped you from doing anything
Coping: How did you react /  What did you say / What did you do / How did other people 
react / What did other people say / What did other people do / What advice would you 
give to someone else in that position
Potential Comments: That must have been difficult / Tell me more about that / That’s 
interesting / How did that make you feel / How did you react / Can you tell me a bit more 
about what that was like / That sounds like a difficult experience / That sounds like fun.
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3) How has having epilepsy effected your life now? (Friends, home-life, school, hobbies)
How do you cope with 
your epilepsy on a dav- 
to-dav basis? 
e.g. tilings you do 
differently because you 
have epilepsy?
In what wav are things 
different for you? What 
wavs do you think you 
might be treated 
differently?
• School
• Hobbies
Do you worry about things 
to do with your epilepsy?
If so. what sort of things do 
you worry about?
1r
What advice would
vou give to a teenager
recently diagnosed
with epilepsv?
What is the biggest impact epilepsy has had on 
your life?
Can you tell me about 
things in vour life which 
have not been effected 
by having epilepsy?
What do other people
think about you having
epilepsy?
• How do parents 
react?
• Friends/Family/other 
s
• How do they know?
• Who do you not tell, 
and why?
• Reactions?
• Do you talk about it 
with people much?
Potential Prompts:
Impact: How did that feel / How did that effect you / did that change the way you behave 
now / Has that incident stopped you from doing anything
Coping: How did you react / What did you say / What did you do / How did other people 
react / What did other people say / What did other people do / What advice would you 
give to someone else in that position
Potential Comments:
That must have been difficult / Tell me more about that / That’s interesting / How did that 
make you feel / How did you react / Can you tell me a bit more about what that was like / 
That sounds like a difficult experience / That sounds like fim.
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4) How do you feel your epilepsy will effect your life in the future?
• Do you know what you want to do when you leave school? Do you think your 
epilepsy will effect that in any way?
• Do you have any worries about the future?
End of Interview
Is there anything else that you think is important that we haven’t talked about?
How did it feel talking about things with me today?
Thank you for taking the time to talk to me. Do you have any questions you want to ask 
about the study, or what we have talked about today?
Thank you.
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APPENDIX 3.5 : Themes and Illustrative Quotes
Quotations followed by «=> Participant number: (sex,age)
___________________________________  Limitations on Activities____________________________________
Restricted independence_______________
• “I am fed up that I cannot go out because I need someone beside me cos I get epilepsy and I just drop down” “So 
you've not been able to go to the cinema, as you’ve been growing up, on your own without an adult What else 
haven’t you been able to do on your own?” “Basically everything” “Can you give me some examples...of err 
things that other people do your age that you...” “Swimming, because you can drown, and I’m, you know, someone 
who wants to go in the deep end. So if I go and if there’s no adult there. ” P01 :(M,12)
•  “When I was at the {2nd School}, they had, because I have epilepsy, they had a bag with my tablets in with them, so I 
couldn’t go... say at lunchtime.. .everyone was allowed to leave out to the playground, I couldn’t because {teacher 2} 
had to stay with me, cos she had my tablets. So, I’d have to stay to the very end, and then go out to the playground.” 
P01:(M,12)
• “so before were you spending a lot of time with adults?” “Yes” “Can you tell me what wasn’t good about that?”
“Ummm - -erm, what wasn’t good about that? - - My sister {sister’s name} could just clear off and go with her pal 
{pal’s name}. I’d have to stay behind with an adult.” “How did that make you feel?” “Err, sad and unhappy - - And 
I’d feel angry aswell” P01 :(M,12)
• So what are the biggest things in your life that have changed because of it?” “Errn...Can’t do certain things with 
my niece, can’t baby-sit her. I can’t go and take her to the shops and that by myself. Just like daft things, but its quite a 
lot to you ” P02:(F,17)
• “Like when I was in the class and I wanted to go to the toilet, you’d to wait for somebody to come with you, and 
like.. .1 can go myself...just things like that....I didn’t have any more privacy any more.” P02:(F,17)
• “My mum is my carer.” “ - - How does she care for you?” “She looks after me all the time.” P04 (F,17)
• “my mum says never to leave me in the jxx>l on my own just in case that I have one,” P06:(F,15)
• “I love swimming (yeh) but you know I have to make sure I’ve got someone with me.” P06:(F, 15)
• “I’m getting older and, when you’re going swimming with your dad, you’re like “oh poor little baby, I’ve got to go 
with someone” so...it’s really go with no-one or go with dad, basically.” P06:(F,17)
• “How would life be better? What is the big thing that would be better?” “- - Eim.. .1 don’t know... well any hour 
off a school is like forbidden, so I have to go to an appointment during the week, they seem to think “oh my god!” I 
think “yes!” An hour off school or something like that Erm... but erm.. .not having to go to appointments, erm.. .being 
allowed to be on my own in a swimming pool, being allowed to drive, you know.. .stuff like that.” P06:(F,15)________
Restricted activities____________________________________________________________________________________
• “So are there things you avoid doing to try and avoid having a fit then?” “Erm...like going to discos...err...going 
to places that might bring on stress, like...dunno...I cannot remember {{participant laughs}} ...err, what else ...” 
P02:(F,17)
• “Discos...do your pals...do they go to (uh huh) when do they go?” “The weekends, and I feel left out...” 
P02:(F,17)
• “Have you ever been a member of any groups, or clubs at any of your schools?” ‘I ’ve asked my mum but she 
won’t let me.”“WiII she not? (no) Why’s that?” “Cos she thinks that I won’t fit in.” “What do you think?” 
“Dunno?” “What sort of clubs have you wanted to join?” “- - Can’t remember there’s - - there’s lots, the last time 
that I had in my mind - - 1 can’t remember now.’’“Cos I guess schools often have, sports dubs don’t they...or music 
clubs... games dubs. Why do you think she thinks you wouldn’t fit in?”“Cos of my epilepsy - -““What do you 
think that’s about? Why does she think your epilepsy would stop you fitting in?”“I won’t fit in with some of the 
people.” “Ok. What bit of your epilepsy?” “Seizures.” P04:(F,17)
• “I just stay in all the time (ok) I’m not allowed out” P04:(F,17)
•  “Why aren’t you allowed to go out?” ‘Cos of my epilepsy (ok) I’m just allowed to take the dog for a walk and 
that’s it.” P04:(F,17)
• “Are there stuff outside you can’t do because you’ve got epilepsy? (yeh) What sort of stuff?” “- - Going to the 
shop when it gets dark - - Cos last time I went to the shop when it was dark I took a seizure - - I had one and then an 
ambulance came, and I burst my lip” P04:(F,17)
• “Did that change anything after that incident? I don’t know whether it changed the way you acted or the way 
you felt or..?” “No not really I’ve just not done a swimming gala since. {{Participant and interviewer laugh}}” “So do 
you still swim, but you just don’t.?” “Yes, I just don’t do competitive swimming.” P05:(F,15)
•  “Is there anything else you can’t do or you’re kind of restricted from doing because of your epilepsy?” “Well, 
my... if you were talking to my teachers they would probably say.. .oh we don’t let her in the swimming pool because 
of her seizures, but that was really because I asked my mum to write a note about that I don’t like swimming with the 
school. I can swim anywhere else, but not with the school. Erm... ” “So is that., was that your choice?” “Yeh, it was 
a made up thing really”P06: (F,15)
•  “Actually one thing that really, really annoyed me... .at the time I was playing for a football team and I was a striker, 
and I wasn’t too bad and I was getting better and better and then they told me I had to take a while out to see if 
headering the ball was effecting it, and it was about a good few months after that they told me I could maybe go back, 
but I never really cottoned on again, and I wasn’t quite the same, and was really err... .well, there’s a few words I could
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come up with to describe how I felt, but.. .1 won’t say it on this.” P07: (M,l 5)
• “Was he saying that you couldn’t play football at all? Or was he...” “He said err., he wanted to see what I was like 
without playing football, see if  it effected my seizures, but I mean, I didn’t really agree to it, but my mum said, “well 
come on see if it helps”, see if football was effecting it, so you don’t diss your mum, I had to.” P07:(M,15)
• “Right. And who’s decision was that? Who decided that?” “The doctor. (Oh was it?) I could have knocked him out 
Oh well, as I say you’ve got to get on with it haven’t you?” “Yeh. So err... how did you react to that when he said 
that?” “Pretty angry. Yeh, one of the things I love was being taken away from me. I was a bit hacked off.” (M,l 5)
• “I had to miss out on some things that didn’t really want epileptics... kind of joining in... erm, like parties for instance. 
Erm, one of my friends {{Name of friend}}, he particularly likes paintballing and err... I really wanted to do it, but I 
couldn’t do it because... err...it has instructions, the rules, for the people that like do the paintballing, that say 
epileptics can’t come... so that annoyed me as well... when all my friends went for a birthday party and I couldn’t join 
them, because of my epilepsy.” P07:(M,15)
• “the things that 1 do are limited, like the paintballing, but I mean I’d love to do that, but I can’t” P07:(M,15)
• “I used to do sports but I had to stop because of the epilepsy.” P08:(M,16)
• “So how come you... why did your epilepsy stop you doing basketball?” “Just with a lot of things like exercise it 
kind of got worse, so I had to stop, cos I had seizures.” P08:(M,16)
• “Is there anything else, any other sports or activities or trips or...” “Nothing that Pm really interested in no. I am 
sure that there are things that I couldn’t have done, but nothing I was interested in ” “Ok. What sort of things might 
they have been? Are there things you are aware of that you...” “Just other sports, other really active sports, and 
that’s about it actually” P08:(M,16)
• “Like Laserquest, sometimes it says no people with epilepsy on this (right) - - ■ and once she took that a wee bit, kind
of... she told me not to go on it,” P09:(M,14)____________________________________________________________
Disruption of activities_________________________________________________________________________________
• “I’m wondering about when you first found out you had epilepsy. Did ...any of your bobbies or interests get 
affected, by that?” “No - - err dancing, if  I get too hot, but I still do the dancing, I just don’t.. .when I get too hot I just 
go and sit down and cool down a \At(ok) that’s all.” P02:(F,17)
• “Do you remember the last time you had a seizure?” “Yes. I was at hockey camp and I was really like warm and I 
was really dehydrated, so I had a seizure in the middle of the warm-up.” P05: (F,15)
• “But then I had a seizure in the middle of the pool (gosh) so that put me off a little bit {{Participant laughs}} ” “Wow. 
Can you tell me a bit about what happened.” “Well we were just doing the warm up and I don’t know, it just 
suddenly came on and.” P05:(F, 15)
• “Well, when I went in to see Harry Potter with my mum and dad I had a big one just before we got in and err mum 
started really panicking and I was like “I’m fine, I’m fine, it will be over in a minute, lets just go inside, and err I think 
I remember holding on to mum, I think I saw this woman above me and I’m like who are you? I like walked away and 
dad pure pulled my away and I’m like “ok, Hi there” and mum started really panicking going ‘W e’ve got to get her out 
of here” and I’m like “what?” P06:(F,15)
• “Yeh, ok, so how did that effect you then, having to go to the hospital and stuff...” “Well I was missing classes. - - 
Missing stuff I should be learning.” P07:(M,15)
• “There’s not really much I can’t do. It’s just that when I have it I can’t do it at the time... .whatever I happened to be 
doing, (ok) I just have to go away and do my own thing...at home.” P08:(M,16)
• “Ok, so what sort of stuff does it get in the way of then...if say you’re having a bad day?” “Anything.. .anything I 
happen to be doing at the time. I’m always dead distracted at the time, because I’m always thinking... am I going to be 
ok without having to go home, or am I going to have to go home and take some tablets or whatever.” P08:(M,16)
• “What is the thing that makes the big impact...what is the impact?” “Just the - - erm - - 1 don’t get to do as much I 
suppose - - and I don’t go to school as much as I could do if I didn’t have epilepsy.” “How much are you missing 
school then?” “Oh, it used to be, last year, the year before it was one/two days a week and this year it’s got better, cos 
its only a couple of periods a week now. (ok) at most.” P:12(M,16)
• “have you had experiences of having a seizure when you’ve been out with your friends in town and stuff... Yeh, 
but it’s never really been a problem. Just take the tablets when I need to, or either go home.” P08:(M,16)
• “I think, in a way everything has probably been effected by epilepsy - - there’s nothing that hasn’t especially been 
effected by it Just, whatever I do is always effected by it, depending on how I feel I suppose.” “Ok. So when you are 
having a really bad day... what you described as a bad day what gets disrupted with that?” “Everything. That 
becomes a day when I sit about doing nothing. - - And whatever I try to do, its always hard to do because I’ve got no 
concentration” P08:(M,16)
• “I was really good at football when I was before that, cos I did goalkeeper and I thought I could make it (yeh) I was 
really good I think. Well.. .all I can remember I was good. But then just after it I forgot how to do it really, so when I 
got back... it kind of supports the clumsiness thing” P09:(M,14)
• “Just cos I was so bad at it, cos I was losing 16 mil and that, cos I just kept... the ball just kept going past me. Just 
couldn’t save anything, so I tried to go outfield and I was even worse, then I just kind of... was fed-up with it... cos they 
kept putting me in goals, I don’t know why, because I was so bad at it.. .couldn’t save anything really.” P09:(M,14)
Minimal Limitations____________________________________________________________________
• “Are there things that you don’t do that you maybe would have done because you have epilepsy now?” “- - erm - 
-I’ve never really thought of that - - no.” P03:(M,16)
• “what’s it been like for you growing up with epilepsy, through your teenage years?” “Urm.. .nothing really, cos 
basically, err I don’t worry about it a lot (no) no. Like I said but, everything’s just stayed the same.” P:07(M,16)
• “Do you think your life has ended up much different that if you hadn’t had epilepsy?” “No. Not at all.” P05:(F, 
15)____________________________________________________________________________________
163
child then?” “1 pretty much went to school and went and saw friends so I don’t think there was much my mum and 
dad didn’t let me do.” P08:(M,16)
• “I didn’t think anything of it. I didn’t think anything of it at all. It didn’t really effect my life at all. Just think nothing of 
it. Just forget about it completely. - - It doesn’t effect me in the day, so I just get on with it.” P09: (M, 14)____________
___________________________________Response to Epilepsy from Others_________________________________ __
Teasine/BuUvins_____________________________________________________________________________
• “I get treated sometimes differently at college. Cos, a lot of the people they do say to me wee jokes about my epilepsy 
and they think its funny but I don’t, so.. .its pretty annoying.” “Can you tell me what sort of things they say?” “Like 
they imitate me taking a fit and just like things like that.. .one falls on the ground and that and start shouting, coh I’m 
taking a fit, I’m taking a fit’, but its not really that funny....” P02:(F,17)
• “What was it like having epilepsy at {{name of primary school}}?” “I got bullied.” “Did you?” “Uh huh” “What 
sort of things happened, in {{name of primary school}}?”“Just like what bullies say.’’“Was it to do with your 
epilepsy?” “Yeh.” P04:(F,17)
• “I guess what I’m wondering is, there’s different types of bullying, sometimes people say things, sometimes 
people do things, what sort of things...” “Well they didn’t want to hang about with me (ok) They didn’t want to sit 
near me... ” P04:(F,17)
• “So after they’d seen you have the seizure, how did they react?” “They didn’t speak to me.” P04:(F,17)
• “When the class found out that you had epilepsy, do you think you were treated differently in any way... after 
that?” “Yes.” “Can you tell me a bit about in what sort of ways?” “Cos, they wouldn’t speak to me and that.” 
P04:(F,17)
•  “I ended up telling one of my teachers about it.. .one of these stupid guys in my class heard me and since then he’s 
been trying to find something wrong with it I’m like “You’re just sick, it’s just wrong” and he’s ... and my tablets fell 
out my bag one time and he went “Ah that says retard cm them, you’re a retard” P06:(F, 15)__________ _____________
Support____________________________________________________________________________
• “They actually take care of me. Ask me if I’m all right” P01 :(M,12)
• “How are they helpful?” “They’d go and get someone, as quick as they can”P01: (M, 12)
• “That sounds quite difficult having to do that, at school (Uh hum). - - Does it worry you about having a seizure when 
you are at school?”“No. Because its {name of special needs school} and I know there’s people there."“And who’s 
helpful? Who’s there for you?”“All, everyone.” P01 :(M,12)
• “Where do you get the most support from?” “My friends.” “In what way?” “They do loads of stuff with me, and 
they don’t put my epilepsy as an excuse all the time...like they kid on that I don’t have it...so...that’s what I like” 
P02:(F,17)
• “I was with my friends...so they helped me up and took me home...so that was that {{participant laughed}}” 
P02:(F,17)
• “But when I fell and I had all my lip was burst in {{name of town}}, everyone was.. .erm.. .caring for me when I went 
back, because they knew that I was in hospital, and they were sad.” “What sort of stuff did they say to you then?” 
“They gave me hugs...and things like that...and said “what did you do to yourself’...slagging me off, like just for a 
laugh.” “Oh, that’s good. So how did you feel that they reacted like that?” “I was laughing.” P04:(F,17)
• “one of the girls went and got the teachers and helped me.” P04:(F,17)
• “ they were great to me.. .being epileptic and all that” “Yeh? How were they great?” “Err well, best mates, and they 
knew exactly what to do if I had a fit, and they’d help.” P07:(M, 15)
• “they all helped me, whenever I had a fit.” “How did they help you, what does help you mean?” “Erm. Make sure I 
don’t hurt myself. Make sure, like I’m safe and... stand by me till the fits over.” P07:(M,15)
• “but some people I’m quite close to, they’ll know exactly what to do and help.” P07:(M,15)
• “most of the time someone will come and help." P07:(M,15)
• “It lasted 15 minutes. Erm, yeh... but my brothers were with me and a few people pulled over at the side of the road to 
help. One person called an ambulance. My younger brother went to the police to try and find my mum.” P07:(M,15)
• “how did they react?” “Well {{Name of friend}} is the best He’ll shove his jumper under my head and just stand by 
and help me whilst other people just stand round and watch - - well actually until the teachers come.. .yeh.” P07.(M,15)
• “ {{Name of previous school}}... when Fd had a few fits, in the medical room, they bought a new bed and it had a 
side... a kinda of cushion side which hung down and you just bring it up around and push it into place so its nice and 
firm, so that I wouldn’t fall out of the bed and the medical room was right beside the office... and they had a part of the 
wall replaced with a window, so that if I felt a fit coming on I would just knock on the window and they would come 
through” P07:(M,15)
• “Yeh, yeh, if I have a fit, either him or {{Name of name of father’s partner}} will come help me, come and take me 
home and look after me. So they’ll come home from work and help m e.. .yeh, look after me (sounds good) Or if  they 
need to go back to work, they will make sure there is someone there to look after me” P07:(M,15)
• “Teachers have always been really good about it Always offered to help when I needed it and just always try to help 
me.” “What’s helpful to you? How do they help?” “Just by going over the stuff that I’ve missed and asking them 
whenever I need help and I don’t understand it because I wasn’t there beforehand.” P08:(M,16)
• “How about, erm - - family? What do they... what are they Kke around your epilepsy.” “They just.. .ah, they try 
to help as much as they can obviously, but again, they can’t really do anything either.. .1 mean, because... there’s not 
really much anyone can do. I just have to take tablets and hope for the best. They’ve always been as supportive as they 
need to.. .just with whatever comes up.” P08:(M,16)
• “ My friends just take me home”. P08:(M, 16)
• “Then I had all the letters and that, from all the people at school... like in school they were all writing letters”_________
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P09:(M,14)________________________________
Not a Significant Issue
(Descriptions where epilepsy is not perceived as being a  significant issue to other people)___________________________
• “Back three years ago when you found out you had epilepsy, how did your friends react to that?” “They didn’t 
treat me any different than I used to be. They just spoke to me as normal, so... {{participant laughs}} ” P02:(F,17)
•  “They do loads of stuff with me, and they don’t put my epilepsy as an excuse all the time.. .like they kid on that I don’t 
have it...so...that’s what I like...{{participant laughs}}” “when you say ‘an excuse* what do you mean by that? 
What sort of things would it be an excuse for?”“Erm - - basically, when we want to go and do something.. .1 can’t 
think of anything but {{participant laughs}} - - if  they want to do something, and I say but I can’t do that because of 
my epilepsy, they say ‘stuff the epilepsy, kid on you don’t have it’, stuff like that {{participant laughs} }.”“So how 
does that make you feel that they react like that?” - Funny - - {{participant laughed}}” P02:(F,17)
• “Right ok. So err with the two friends that do know you’ve got epilepsy, do you ever talk with them about 
it?”“Not about it nah.” “No. Are they., would you say they are quite supportive....or?” ‘T just say its basically 
like the usual, its no like anything that comes up all the time. Its only maybe been brought up once.” P03:(M,16)
• “They knew.. .1 had epilepsy.” “And how did they...” “They didn’t mind.” P04:(F,17)
•  “1 was just wondering what your friends and your classmates kind of made of you having epilepsy as you were 
growing up?” “Erm. - - They don’t really take much notice of it actually. It doesn’t really affect any things - - it 
doesn’t really have much relevance to be honest” P05:(F,15)
• “Like, do you think of it in a different way than you maybe did when you did when you were younger or not?” 
“No not really I just think other people probably view it in a different way. Like it doesn’t really bother them.” P05:(F, 
15)
•  “People in school don’t really care about my epilepsy so...” P06:(F,15)
• “Everyone else is like, “Oh, Ok die’s having a seizure, leave her to it!” P06:(F,15)
• “did your epilepsy get in the way of your friendships at all...in any other way?” “Not really no... mo.. .they all 
accepted I had epilepsy and they all helped me, whenever I had a fit” P07:(M,15)
• “are there other things in your life, that haven’t been effected by epilepsy at all?” “Erm. ..well my friends...still 
are great pals with them down there.” P07:(M,15)
• “they probably said one day, why have you been off and I said cos I’ve got epilepsy, so its fine. They’ve never had a 
problem with it either.” P08:(M,16)
• “what do you think they think about you having the seizures?” “Honestly have no idea. I am sure they just find it 
fine and don’t really have any problems with it They’ve certainly never brought anything up” P08:(M,16)
• “what do your friends think about you having epilepsy, you’ve talked about how they react when you 
tell them ...” “I think it’s all right. Nobody says anything about it - - no-one thinks about it...about
anything I don’t think.” PQ9(M, 14)_______________________________________________________________
Anxiety___________________________________________________________________________________ _________
•  And how did she react at the time?” “She was shocked Shocked and terrified - - so....” P02.(F, 17)
• “my dad he’s hardly around to see them, so...sometimes he feels bad that he misses me taking a fit, and he’s not
there... and I’d rather he just... he doesn’t know what to do...he’s always...I don’t know.” “He doesn’t know what to 
do? - - if you’re having a fit?”“He does know, but he’s in a panic, so. ..that’s that {{participant laughs}}” P02:(F,17)
• “Did other people start acting differently? (No). No, just die teachers, and what sort of things did they do?”
“They were dead clingy and dead protective, and....” P02:(F,17)
• “what do you think your mum thinks about your epilepsy?” “She’s worried.” “What does she worry about?” “- - 
Me.” P04:(F, 17)
• “did you ever have a seizure in front of them?” “Uh hum.” “And how did they react to that?” “They were 
shocked and scared.” “Ok. “ “But they got used to it after a while.” P04:(F,17)
• “Did you have any seizures when you were at {{name of special needs secondary school}}?” “Erm - - 1 think so? -
- Yeh, I did.” “And how did they react when...” “Erm, one of the girls panicked... P04:(F,17)
•  “Ok. So you were out on the hockey pitch (yeh, uh huh) So that was quite busy, everyone was around (uh huh) 
What was that like? Can you tell me a bit about that?” “Erm - -It was quite embarrassing actually, cos everyone 
was just like ‘What the hell?”’ P05:(F,15)
• “What sort of stuff erm is she cautious about?” “I don’t know, she just...I don’t know, she just gets really worried 
and is like don’t do this, don’t do that, and be careful with this - P05:(F,15)
• “What are things like at school? I don’t know maybe in terms of how the teachers reacted to you?” “Urmm. 
They were always a bit, sort of too cautious. They kind of... I don’t know exaggerated a little bit, which is kind of a 
bit annoying, but I don’t know, that’s it really...” “Can you give me an example of what sort of stuff...” “I don’t 
know - - like if we went on school trips or anything everyone was always just constantly asking me like if I was alright 
and everything? Which was quite annoying, but?” P05:(F,15)
• “What about what...how other people reacted, like...I don’t know...your friends for example?” “Well they were 
really freaked out. I took one on the way home from school, one time and was like “{{name of friend}} you’re going to 
have to help me out, yeh I’m having a seizure” die was like “What! What! Oh my god!” and she was “Ok, hold onto 
my shoulders, hold on” I’m like “{{name of friend}}, I’m all right ok” she’s like “just keep walking! Keep walking!” 
P06:(F,15)
• “Well, when I went in to see Harry Potter with my mum and dad I had a big one just before we got in and err mum 
started really panicking and I was like “I’m fine, I’m fine, it will be over in a minute, lets just go inside, and err I think 
I remember holding on to mum, I think I saw this woman above me and I’m like who are you? I like walked away and 
dad pure pulled my away and I’m like “ok, Hi there” and mum started really panicking going “We’ve got to get her out 
of here” and I’m like “what?” P06:(F,f 5)______________________________________________________
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•  “One time on MSN I like put I’m not feeling too good I’m going to go off-line for a bit, she wrote “WHAT!” in big 
capital letters “What! Are you ok, are you really ok?” and she’s like ‘Tm coming over!” I’m like BB I’m fine!” “And 
what’s that reaction Iike?”“Its really funny when they start screaming! {{participant laughs}} pure like “What! 
What!” erm...” P06:(F,15)
• .. she worries a lot actually.” P06:(F, 15)
• “Well during a sleep over I forgot to take my tablets and err I was fine I wasn’t having any seizures, I was sound asleep 
and got woken up by my pal going “{{participant’s name}}, {{participant’s name}}” “What, what is it?” If someone 
wakes me up, oh my god you are going to get the wrath of {{participant’s name}}.{{Participant laughs}} 
“ {{participant’s name}}, {{participant’s name}} wake up” I was like “what is it?” You haven’t taken you tablets.” I’m 
like “is that it? I thought the house was on fire.” She’s like, “well go and take your tablets”, and I was like, “no I’m 
fine, go back to sleep. If I’ve not had anything I’ll be fine.” She was like “no I want you to take your tablets.” “But I’ll 
be fine.” “I want you to take your tablets. For me, it will put my mind at rest,” I’m like, “ok then. Right Now go to 
sleep.” “Take your tablets!” “Ok, ok then.” “Did you give in?” “Yeh, “oh god I’m going to kill you in the morning” 
she’s like, “yeh I know, I know. But you’ll be ok now”. I was like “I was ok anyway!””P06:(F,15)
• “What do you think they thing about you having epilepsy.” “They worry. They worry a lot Erm...” P06:(F,15)
• “So does she worry about your epilepsy?” “Yeh. Usually if I have to stay over at hers I come down, take my tablets 
and before I’ve got them to my mouth “Have you taken your tablets??” Like “Yeh, I’ve just taken them, like a second 
ago!” P06:(F,15)
• “how do people react when you have them?” “Like I had a wee come and go one in the pool and...that’s just like 
when it started and went away...like immediately. I went “oh, dad.. .1 just had a wee one there a wee seizure.” He was 
like “what! Get out here!” I’m like “dad its over now! It was over like five minutes ago.” P06:(F, 15)
•  “It depends who it is. I mean some people think, what’s going on? What is this? Just not have a clue what to do.” 
P07:(M,15)
• “The people that don’t understand. How do they react then? The people that don’t really...” “Err - - scream for 
help... and just like before I go completely into the fit, Fll maybe ask than to do something, maybe hold my head or 
something, make sure I don’t hit it off the ground, but they’ll just stand there looking at me - - and I’d think to 
myself... if I was that guy over there I’d punch him. But, o r  -  yeh it can be frustrating when I ask them to do 
something which can help me from hurting myself too much and they just stand there watching me (yeh) rather than do 
anything about it” P07:(M,15)
• “My headteacher at primary...he really liked me, but I think he was just scared.” “Was he? What was he scared 
about?” “Well just in case anything happened, he just treated me good. Just treated me pretty good, so.” “What do 
you think he was scared would happen?” “If I had a seizure, he would have to deal with it (ok) So he treated me 
well.. .he treated me diff...everyone else he didn’t treat well, it was only me.” P09(M,14)
• “were there other people you maybe think were scared of....” “Yeh. One time in primary five my teacher....she 
went and said...one time... there was a nutter in the class, he punched me in the face once... well he punched everyone 
anyway...cos he’s a nutter, but she just shouted it out, “He’s got epilepsy you know” and all this....I think she might 
have been a wee bit.. P09:(M,14)___________________________________________________ ________________
______________________________________ Potential Negative Impacts _____________________________________
Discrimination____________________________________________________________________________
• “... and was that, erm...a difficult decision to make? Whether to tell them.”
• “Yeh, cos.. .for example, for my work, I didn’t know if I told them they would fire me, cos.. and then.. .but they didn’t, 
so it doesn’t matter. {{participant laughs}}” P02:(F,12)
• “...so why would you not have a quiet life if people knew, do you think?” “I don’t know...err...basically because 
I’d get the piss took out of me... for it all the time.” “Yeh? (uh huh) Who would that be? Would that be your 
friends or....at school...?” “Well if  I get bullied... well if  I told one person in school and it started spreading around - 
- and then I’d get the piss took out of me.” P03:(M,16)
• “...everyone takes the piss out of everyone for the slightest reason.” “Right ok, so epilepsy would be...” 
“Err... something that I’d never be able to live down.” P03:(M,16)
• “See erm, your friends. Do you think they’d take the piss out of you if they knew?” “Well - - some of them. See 
of them I’ve already told, like the people I can trust, I’ve already told (oh right). Aye, they’d take the piss out of me.” 
P03:(M,16)
• “so you feel embarrassed about other people knowing that you have epilepsy?” “Yeh - - if  they don’t have a 
disability.” “Ok - - do you feel anything else about it?” “No.” “What are you embarrassed about? Do you 
know?” “Just if they laugh at me.” P04:(F,17)
• Last time I got a like a wee questionnaire on this, my dad kept saying “oh but she’s very bright, she’s great at school!” 
and afterwards he was like, I just didn’t want ho- to think that because you’ve got epilepsy that you’re dumb. I’m like 
“no, would she actually think that?” cos.. .1 do get on pretty well at school, or so my dad and mum keep saying. I keep 
thinking “Oh it’s too hard, this is too hard”.”P06:(F,l 5)
• “I never thought of it until dad like mentioned it, but that’s people that don’t really know me. People at school know I 
am pretty bright I’ve had quite a few pretty good praise like from teachers, so I don’t really... so I don’t really care if 
people I don’t know think I’m dumb, again erm.. .just people in school know I’m not dumb and people in school don’t 
really care about my epilepsy so... they think “oh she’s smart” - - epilepsy is nothing to do with it anyway.” P06:(F, 15)
• “I’m not actually sure if like I apply for a job it will effect it sometimes.” “How might it effect... ” “I don’t know... I 
think I’ve seen a programme it happens, like they don’t want to do it in case anything happens....(ok) they don’t like 
employ someone in case anything happens (ok) don’t get any risks.” P09(M,14) ______________________________
Risk of seizure-related death__________________________________________________________________
• - Can you give me some examples...of err things that other people do your age that you...” “Swimming,
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because you can drown, and I’m, you know, someone who wants to go in the deep end. So if I go and if there’s no 
adult there...” P01 :(M,12)
• “I just wondered whether there’s anything you woriy about to do with your epilepsy?” “Erm - - 1 don’t know? 
My heart goes fast, maybe it will pop.” P01 :(M,12)
• “And then, one of my pals, he died. He had epilepsy. He and err...we were at swimming and he drowned. Cos 
everybody thought he was playing hide and seek, and then 10 minutes later we couldn’t find him, and then err, they 
grabbed him out of the pool, and we saw his body down at the bottom of the pool... so.. .and that was showing me that 
err...people should like worry about me {{participant laughs}}” “That sounds like an awful thing to witness...go 
through...” “It was...and then at that time when my pal died I had God knows how many fits because...stress came 
on...so....” “So how did things change for you after...so you were saying you had more fits...” “I lost a lot...I 
kept worrying that it might happen to me next, and my mum keeps telling me not to think that.. .and err...what else 
{{participant laughs} }err.. .that’s it...” P02:(F,17)
• “What did you used to worry about...what were your biggest worries?” “That I was going to take a fit when I 
cross the road” P02:(F,17)
• “... and I had one... a quite scary one in the bath.. .my mum said if I was any shorter I would have drowned.. .1 was like 
‘thanks!’ {{participantlaughs}} (ohgosh)...erm...so...” P02:(F, 17)
• “I just wonder, do you worry about anything to do with your epilepsy at all?” “Erm - -well yeh sometimes I do 
worry about finding myself in sticky situations, but not really to a great extent” “What would be your description of 
a sticky situation?” “Erm - - just having a seizure somewhere where - - like I - - just actually in general having a 
seizure somewhere like where I would be in any kind of danger, like.” P05:(F,15)
• “What do you worry might happen?” “Erm - - I don’t know, just like if I have a seizure half way down and kill 
myself or something like that Like, cos. It could be quite dangerous because you go so fast, (yeh) I could like fall off a 
cliff or something like that” P05:(F,15)________________________________________________________________
Future limitations_____________________________________________________________________________________
• “So if you want to be an actor and a singer, do you think your epilepsy will affect that in anyway?” “Staying up 
late, jumping about die stage, filming movies maybe - - late at night? I don’t know, maybe yes, it probably would.” 
{{the participant has a high frequency c f  night-time seizures}} P01:(M,12)
• “Do you have any worries about the future?” “Aye, about my kids, if my medication will affect my kids, err... I 
hope it doesn’t, but the doctor said they don’t really know (ok) so.. .1 hope not... ” P02:(F,12)
• “Do you have any worries for the future, I mean as an adult? Growing up into adulthood? Anything about how 
it will be like living with epilepsy?” “Well if I’m not allowed to drive I would be really pissed off.” P05:(F,17)
• “How about, does epilepsy get in the way of any of these other interests or hobbies.” “Well my mum said I may 
not be able to drive if I’m not free from a seizure for a year... ” P06:(F,15)
• “Guess the driving thing is quite a big impact, because you know it would be quite handy to drive” P06:(F,15)
• “Do you think having epilepsy is going to interfere with your plan to be a PE teacher at aU? Oh, I mean it 
shouldn’t do, I don’t think... .1 mean, I’ve asked a few teachers, but I mean.. .1 doubt a school would like a teacher 
wriggling about on the floor in front of his class.... But I mean, hopefully it will pass through my teenage
years.... fingers crossed... ” P07:(M, 15)
• “Erm, I don’t know.. .if I’ve still got it and I’m living on my own and something... then god knows what will happen.” 
P07:(M,15)
• “Well I am just worried... well, that it will get better so I can go to college and get a job and that... erm... I never really 
worry about much else than that” “Ok. So your plan is to go to uni and then do {name of course}. So how do you 
think epilepsy might get in the way with that? What is your worry there?” “That I’m not going to get 
enough... either time next year to get the highers I need next year to go to uni... Or when I’m at uni I’m going to be off 
and not going to be there enough to get what I need. ..for a good job.” P08:(M, 16)______________________________
____________________________________ Disclosure of Epilepsy to Others____________________________________
Selective disclosure__________________________________________________________________ _________________
• “So who does know?” “Well basically my family and that’s i t ” “Ok. How about School?” “Aye. Yeh my teachers 
know.” P03:(M,16)
• “Ok - - Just thinking about your friends...you've not given me their names, but the small group of friends you 
hang around with. Do they know that you’ve got epilepsy?” “No.” “They don’t ” “Uh hum.” “So erm. Why is 
that? (what?) How come they don’t know you’ve got epilepsy.” “I don’t know. I just decided not to tell them.” 
“Can you tell me a bit about why you decided...why did you decide that?” “Err...cos I probably thought that it 
was none of their business.” P03:(M,16)
• “Some of them I’ve already told, like the people I can trust, I’ve already told” P03:(M,16)
• “How many people is that that you’ve told then, that are close?” “Two.” “And what makes them trustworthy? 
What makes you be able to trust them?” “Well erm.. .one of them I’ve known since primary and erm... another one, 
basically, she stays far away, so she’H never get to see my friends.” P03:(M,16)
• “Some of the girls knew.” “Did you tell them, or?” “I told them.” “Ok. Were they... why did you...I guess you 
can choose to tell someone you have epilepsy, or you can choose not to tell someone (Hum) Why did you decide 
to tell...” “The lecturer asked me to choose, who I wanted to tell, cos it was my first day, so I had someone to hang 
about with - - so they would know.” P04:(F,17)
• “So why did you decide not to tell anyone at {{name of mainstream secondary school}}?” “Because in our class 
there were only two girls - - and the rest boys.” P04:(F,17)
• “Do people at {{name of college}} know that you’ve got epilepsy?” “Just a couple.” “Yeh? Erm - - how do they 
know?” “Cos I told them.” “And why did you decide to tell them?” “Because they came up to me, something - - 
talking about disabled things their selves- - their own disabled problems, so (ok) I got into a wee conversation with a
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girl and I told her.” P04:(F,17)
•  “Do you have friends that don’t know you have epilepsy?” “Sane, yeh.” “And why did you decide not to tell 
them?” “I don’t know - - 1 don’t know them really well.” “Ok - - So - - knowing someone really well would be a 
reason why you would tell them?” “Yeh - - and of their personality.... if they’re like...if they tell... if they pass on 
things...can’t keep a secret (ok) Do you know what I mean?” “Yes I do. So you are more likely to tell someone if 
they can keep secrets (yeh)” P04:(F,17)
•  “Why would you want them to keep it a secret?” “Cos it’s embarrassing, everyone knowing.” “Ok - - so you feel 
embarrassed about other people knowing that you have epilepsy?” “Yeh - - if they don’t have a disability.” 
P04:(F,17)
•  “So what happened at {{name of mainstream secondary school}}?” “I didn’t tell.” “You didn’t tell? So people 
didn’t know at {{name of mainstream secondary school}}. Ok - - erm. Did anybody know at {{name of 
mainstream secondary school}} School at all?” “I didn’t have any friends at {{name of mainstream secondary 
school}}.” P04:(F, 17)
• “I wonder, like growing up, whether - - who knew you had epilepsy?” “Erm - - not many people actually. Cos I just 
really... I think my mum was like, make sure you tell this person and make sure you tell this person. But I didn’t really,
I didn’t tend to tell many people, just a few people.” “Who were the few people that you..?” “Erm - - like my friend 
{{name of friend}} she’s been my best friend since I was about three, so - P05:(F,15)
• “Why did you decide not to tell them?” “Erin - - I don’t know, I think I just found it quite embarrassing to be 
honest, like. Erm - - 1 don’t even know, like - - 1 couldn’t actually tell you the answer to that.” P05:(F,15)
•  “I don’t tell anyone that don’t think...know me really. I only tell anyone that’s good friends.” “Ok. Is there a reason 
why you wouldn’t?” “Well....no, I just wouldn’t tell them. It was only... remember I said like.... it was only in 
conversation I said I had epilepsy (yeh) like that...between friends and that....then I would say it.. .but I mean the 
people I don’t know... .1 wouldn’t say it to.” P09(M,14)_____________________________________________
Comfortable with Disclosure_______________________________________________________________ _____________
• “And did you tell him that you had epilepsy, or did someone else tell him.” ’Well they know. There is a reason for 
why they do these schools you know. {1st School} ’s a special needs school, the {2nd School} ’s a mixture and {current 
school}’s a special needs school. So, I’d be in die section of special needs in the {2nd School}, so (friend 3} would 
have known yes, or he would have found out Somebody told him. Or maybe I would have told him. I probably told 
him.” “If you were to make a new friend, would you probably tell them you have epilepsy (yes) - - Would that be 
easy to do?” “Erm, - - yes. I’d just tell them” P01:(M,12)
• “...are there any times that you’ve kind of made a conscious decision that I’m not going to tell... such a body 
that I’ve...” “No...cos there’s no point hiding it cos they’ll find out sooner or later. Just in case you take a fit in front 
of them. So. Might as well just tell them...” P02:(F,17)
• “who knows that you have epilepsy? So I know that your family knows and your best pals know...” “Everybody 
knows.” “Everybody knows, ok And how has everybody found out?”“I either tell them, or one of my friends tell 
them.” P02:(F,17)
• “So how come you came to that decision? Why did you...”“Cos its right to tell them Tell your boss that you’ve got 
epilepsy.. .so...” P02:(F,17)
• “And I am just wondering what your view is on telling people that you meet that you’ve got epilepsy.” “Well if it 
comes up in conversation, fine, but I am not going to go out of my way and announce it.”P05: (F,l 5)
•  So how about all your friends written here, do they know?” “Yeh they do cos they are sort of more recent friends 
so... it doesn’t really bother me anymore like.” “So you are saying it doesn’t really bother you any more, does that 
mean...I’m not sure...are you saying that you are not as embarrassed?” “Uh huh yeh.” P05:(F,15)
• “I’m wondering whether you told your friends...cos I guess with epilepsy you can choose to tell people you’ve 
got it or sometimes choose not to. Did you...” “Tell people.... well I’m not really embarrassed of it, so...err....ended 
up telling them anyway, so... well it wasn’t like a formal thing “by the way, sit down I’ve got epilepsy” It was just a 
“I’m not feeling too good” “do you want a glass of water” ‘N o hang on a sec. I am just having a seizure” they’re like 
“What’s that” and I’m like “Ok, I’m going to have to tell you now!” (ok) Yeh, I am not really embarrassed about it, 
so.. .it came naturally really.” P06:(F,15)
• “well it wasn’t like a formal thing “by the way, sit down I’ve got epilepsy” It was just a “I’m not feeling too good”
“do you want a glass of water” ‘N o hang on a sec. I am just having a seizure” they’re like “What’s that” and I’m like 
“Ok, I’m going to have to tell you now!” (ok) Yeh, I am not really embarrassed about it, so... it came naturally really.” 
P06:(F,15)
• “And did you actually tell them that you’d got epilepsy or...” “Yes...I just told them what they had to do and they 
did it” “Ok I guess people can choose whether to tell people or not tell people...”“Oh yeh, well its hard to keep 
secret isn’t it... when I’m rolling about on my back.” “Ok, so was that not a difficult decision to make then, whether 
to tell people?” ‘No, no!” P07:(M,15)
• “in moving to a new place, you again had to tell people - - what was that like?” “It was fine, just had to tell them 
what it was like.” P07:(M,15)
• “Ok so when you first met your group of friends, how did that come up then?” “Oh, I don’t remember it was so 
long ago... they probably said one day, why have you been off and I said cos I’ve got epilepsy, so its fine. They’ve 
never had a problem with it either.” P08:(M, 16)
• “I’ve got no problem hiding it, I mean I don’t need to hide it  I’ve never hidden it from anybody actually.. erm.. .its 
always something I can admit to... Not really a problem.” (M,16)
• “Anyone that spoke to me about it I don’t feel the need to go around telling everyone. Just when anyone asked about it 
I would tell them.” (M,16)
• “I just told... .1 don’t tell them like, I don’t tell them, but sometimes they ask, (ok) when it gets around a wee bit, .but I
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don’t tell them in conversation... I just talk about other things normally.” “Yeh ok. But if someone were to ask you 
then...” “Yeh, I’d say yeh, just casually.” P09(M,14).
• “How many people do you think do know then?” “Well I think all my class in primary, yeh.” “They all knew?” 
“Yeh... Most people in high school and mo...some people at golf.” P09(M,14)
• “They were saying like he had epilepsy and then I said I’d got it as well.” P09(M, 14)____________________________
____________________________________Pro-active Responses to Impact____________________________________
Getting on with Life__________________________________________________________________________________
• “Although I have started, you know {cousin 1}? ({cousin I}? That cousin there? yeh?) I started, I’ve been to see two 
movies now, I’ve just started going to the cinema with her, with no adults, so that’s something.” P01 :(M,12)
• “Did ... any of your hobbies or interests get affected, by that?” “No - - err dancing, if  I get too hot, but I still do the 
dancing, I just don’t.. .when I get too hot I just go and sit down and cool down a bit. (ok) that’s all.” P02:(M,17)
• “I told my dance teacher and then she said ‘don’t let it effect your dancing’, so I just didn’t .. .1 just got on with my 
dancing as usual.” P02:(F,17)
• “If you were to meet someone who had just been diagnosed, today with epilepsy, what advice would you give 
them? If you could think of some really good advice that would kind of help them cope and get them through?”
“Don’t put your epilepsy in the way of everything else. PQ2:(F,17)
• “I love skiing.” “And your epilepsy, does that limit that in any way?” “No - - well I do - - I sometimes do get quite 
worried, but I would rather ski than not ski, so... (ok) - - So I just sort of forget about it.” P05:(F, 15)
• “Erm... so I can’t really say that’s a big effect cos nothing’s going to keep me out the pool, I love swimming (yeh) but 
you know I have to make sure I’ve got someone with me.” P06:(F,15)
• “Well it hasn’t been too nice, but - - fine. Just had to get on with it I mean, just let the fits pass and then carry on with 
what I’m normally doing.” P07:(M,15)
• “Well I just take my medicine and try to carry on with my life. Just go ahead with whatever I’ve got planned for the 
day.” P07:(M,15)
• “And now you know a bit more about it, how do you fed?” ‘Well I’d prefer if I didn’t have it, but I’ve got it and
I’ve got to get on with it.” P07:(M,15)
• “I was kind of gutted about football, erm, but then I tried to think, tried to find other sports I was good at ..(ok) I found 
skateboarding for a while, but then...I couldn’t improve and I hit myself in the face with a skateboard once (oh dear) 
But then I found golf and that was pretty good.” P09:(M,14)
• “I forgot all the things to do, all the skills and that I kind of got fed up with it.- - But everything else.. .Mien I got new 
skills I was ok. Just got to try to forget about i t” F09:(M,14)
• “Are there things you avoid?” “No. I just try and have a normal life.” P09:(M, 14)_____________________________
Confront teasing________________________________________________________________________________ ____
• “And how do you cope with that? How do you react?” “I keep telling them to stop it, and if they don’t stop I’ll go 
and tell err the head of the college.. .and.. .but they don’t listen, but I’ll still go and tell the head.. .even though.. .1 don’t 
care what they think...if I’m a wee grass bag, but...its to make them stop, so...” “Do you think you will end up 
telling?” “Yeh {{participant laughs)}” PG2 :(F,17)
• “I ended up telling one of my teachers about it...one of these stupid guys in my class heard me and since then he’s 
been trying to find something wrong with it I’m like “You’re just sick, it’s just wrong” and he’s... and my tablets fell 
out my bag one time and he went “Ah that says retard mi them, you’re a retard” that’s just stupid. I’m like “I don’t 
know why it says retard on them, you’re just being stupid, you’re just finding anything wrong with this” P06:(F,15)
• “Erm.. .and so since then he was making fun of me and I just called him on it an was “You’re just sick if you are just 
making fun of someone because they’ve got a problem with an illness or something like that, so you’re just being 
sicko” he’s like “I don’t care, bye” and he hasn’t said anything since, so...” P06.(F,15)
•  “But no, no-one’s teased me (that’s great) - - I’d have them if  they did (yeh?) Yeh - - 1 mean I don’t often get in fights 
and that, but if someone were to tease me about something that I have to put up with, and I’ve got to put up with, like 
throughout my life, or so it has been for four years, I wouldn’t be so happy.” P07:(M,15)__________________
